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ABSTRACT 
 
 Filariasis and onchocerciasis are debilitating diseases affecting 120 million 
people globally.  The massive socio-economic impact of these diseases energized the 
international community to declare a goal of eliminating filariasis 2020.  This resulted in 
a dramatic increase in the efforts to eliminate filariasis and onchocerciasis, employing a 
strategy of mass drug administration (MDA).  However, these programs rely upon the 
small arsenal of drugs.  This leaves these programs vulnerable to failure in the face of 
developing resistance and local intolerance to the current drug regimens.  Thus, new 
drugs against these infections are critically needed. A homologue of the ecdysone 
receptor (EcR), a master regulator of development in insects, has been identified in B. 
malayi. The potential of the EcR as a drug target has been underscored by work in the 
agricultural industry, where insecticides targeting the ecdysone developmental pathway 
are effective and non-toxic to non-target species.  As the EcR is absent in humans, it 
represents an attractive potential chemotherapeutic target. The first study investigates 
the hypothesis that the ecdysone receptor controls the embryogenesis and molting in 
the filarial parasite. In-vitro embryogram and in-vivo phenotypic studies were conducted 
to delineate the effect of 20-hydroxyecdysone on the Brugia malayi parasites. The 
results suggest that the hormone accelerates embryogenesis and causes precocious 
molts, resulting in the death of the parasite.  Further, transcriptomic and proteomic 
analysis of the ecdysone treated worms provided evidence that the up-regulated genes 
! vii 
participate in embryogenesis. Based upon the validation of the ecdysone receptor as a 
potential drug target, subsequent studies focused on the development of a drug 
discovery model to screen for agonists and antagonists of the B. malayi ecdysone 
receptor. A stable cell line was created to aid the high throughput screening to rapidly 
identity agonist and antagonist compounds. A total of 7 agonists and 2 antagonists were 
identified. A homology model of the BmEcR ligand-binding domain was created as an 
alternate method for virtual screening of small molecules as well as to study the ligand-
receptor interactions. The hits identified with the assay were docked in the active site of 
the BmEcR homology model providing an excellent correspondence of data between 
the molecular assay and the virtual screening method.  
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CHAPTER ONE  
 
INTRODUCTION 
 
 
Current Scenario of the Parasitic Nematodes 
 
 The phylum nematoda consists of round worms with more than 25,000 species 
described.  Members of this phylum can be free-living or parasitic in nature [1, 2]. A 
large number of these species are parasites of humans. Over 2 billion people in 
developing countries harbor more than one species of parasitic nematode [3]. Filarial 
nematodes and soil-transmitted nematodes pose a serious threat to health of individuals 
and livestock. Onchocerca volvulus, a filarial nematode parasite of humans, causes 
severe debilitating pathologies that range from dermatitis to vision loss [4]. 
Gastrointestinal nematodes cause nutritional deficiencies, anemia, growth problems and 
cognitive deficiencies in school aged children [5, 6]. Apart from the health impacts, 
parasitic nematodes have caused significant economic losses. Ascaris suum infection 
results in an annual economic loss of $155 million in the US alone [7]. Agricultural loss 
caused by parasitic nematodes is estimated to total more than $100 billion globally [8].  
 
 The overall impact of parasitic nematodes on human health is significant. The 
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absence of vaccines aggravates the problem.  Most of the prevention and control 
program depend upon chemotherapeutic agents [9].  Anti-helmintic drugs like 
Ivermectin, benzimidazoles and levimasoles are available, but fall short given the 
diversity of the parasitic species and the population at risk [10].  More than 1500 new 
drugs have been introduced in market since 1975, but only two of them (albendazole 
and ivermectin) have been approved to treat the human nematode infections [11, 12]. 
Ivermectin and diethylcaramazine (DEC) have been used to treat lymphatic filariasis. 
These drugs successfully eliminate the microfilariae from the circulation of an infected 
individual and hence prove to be essential microfilaricidals [13-16]. Drugs that target 
adults are yet to be identified and the need for a potent macrofilaricide is ever growing.  
 
 Intensive use of broad-spectrum anti-helmintics like albendazoles and ivermectin 
have led to occurrences of drug resistance [17]. Studies have demonstrated 
development of benzimidazole resistance-associated mutations in the filarial nematode 
Wuchereria bancrofti [18]. Levamisole, a drug targeting the nicotinic acetylcholine 
receptor was introduced in 1970 and resistance was conformed in 1979 in 
Trichostrongylus colubriformis 10 301 [9, 19]. A detailed understanding of the nematode 
parasites is essential to develop newer and effective chemotherapeutic agents.  
 
 Parasitic nematodes pose a serious public health problem and inflict debilitating 
lifelong morbidity and mortality in the endemic countries [20]. A better understanding of 
the parasites biochemistry and physiology is necessary in order to develop new and 
novel anthelmintic drugs to combat parasitic nematode development.  
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Overview of the Lymphatic Filariasis (LF) 
 Filarioidea are a superfamily within the order Spirurida, comprising nematodes 
that parasitize variety of amphibian to mammalian species. An insect vector plays an 
important role in the developmental cycle of the filarial worms. Lymphatic Filariasis (LF) 
is caused by Wuchereria bancrofti (accounting for approximately 90% of cases), Brugia 
malayi and Brugia timori [21]. Lymphatic filariasis has been identified as the second 
leading cause of infection resulting in permanent and long-term disability [22]. It is 
estimated that more than 1.23 billion people in 58 countries globally are at risk for 
lymphatic filariasis. More than 120 million people are infected and carrying the burden of 
the disease. Approximately 40 million people live with disability and deformity affecting 
their livelihood[3, 23]. As a result, the World Health Assembly’s International Task Force 
has identified LF as one of six Neglected Tropical diseases targeted for elimination [24].  
 
 Pathogenesis 
 The normal lymphatic vessels arise in the upper dermis channeling through 
lymphatic vessels draining directly into the lymph nodes [25]. In lymphatic filariasis, the 
lymphatic channels are dilated and the flow of lymph is compromised. The peripheral 
lymphatic system is overloaded by the demands of the venous supply. Hence, severe 
edema of skin and subcutaneous tissue is observed [25, 26]. The damage to the 
lymphatic vessels occurs due to mechanical trauma cause by microfilariae [27, 28]. The 
larva triggers a host immune response leading to phagocytosis and microfilarial 
degeneration [28-33]. The immune responses further stimulate lymphatic vessel 
dilation. Wolbachia, an endosymbiont of the parasite also elicits immune responses 
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contributing to the lymphatic vessel injury [34].  
 
 Lymphatic filariasis display variety of clinical symptoms, that range from being 
asymptomatic case to a fulminant inflammatory and edematous condition [35]. The 
upright human posture leads to collection of lymph in the legs. A normal healthy 
lymphatic system is capable of draining the vessels. But, in LF, a chronic lymphatic 
failure leads to limb immobility in the dependent position [25]. Extravasation and 
accumulation of fluid in the tissue leads to edema generally in the legs and genitilia, 
which is also less commonly observed in the breast tissue and arms [26]. 
 
 Life cycle of the Brugia malayi  
 The human filarial parasites require a mosquito intermediate host for 
development while propagating through human and a few other mammalian definitive 
hosts [36]. The mosquitoes of genera Mansonia, Aedes, Anopleles and Culex serve as 
natural vectors for lymphatic filariasis [37]. Mosquitoes bite an infected host and ingest 
circulating microfilariae during blood meal as seen in Figure 1. Inside the mosquito, the 
microfilariae sense a temperature and environmental change [38-41]. They penetrate 
and gain access to hemocoel within a few hours of ingestion [25]. They migrate through 
the hemolymph to the thoracic musculature [37, 42]. They harbor in the flight muscles 
and develop into non-feeding sausage-shaped L1 larvae. The parasite molts from L1 to 
L2 in the flight muscles. The L2 stage larva quickly elongates and increases several 
times in length by feeding on the mosquito cellular components. The L2 stage larva molt 
into L3 infective stage larva [43]. Overall, the larva grows from ~200 µm to fully grown 
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infective stage larva (L3) ~1350 µm within the mosquito in a span of 10-12 days [42]. 
The L3 stage larva migrate to the proboscis of the mosquito until the mosquito takes its 
next blood meal 56 [37]. When the mosquito bites a new mammalian host, the L3 larva 
exits the labellum of the mosquito proboscis into the host skin.  
 In the new mammalian host, the infectious L3s migrate to the lymphatic vessels 
where they undergo two additional molts transforming into L4s and finally adults [37]. 
The adults mature into male and female worms in approximately a year. The adults can 
live in the lymphatic system for 10-15 years. The female worm matures and begins 
mating, producing large number of microfilariae. The microfilariae enter the blood 
stream and are picked up by a new mosquito [44], perpetuating the lifecycle.  
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Figure 1.1: The figure from Center for Disease Control filariasis webpage showing the life cycle of Brugia 
malayi.[45]  
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 Geographic distribution 
 Filarial infections are endemic to more than 80 countries in the tropics as shown 
in figure 1.2. They pose a big problem in South-East Asia, Africa, the Western Pacific 
and part of the Americas. Around 80 % of the burden of the disease is concentrated in 
the 10 countries: Bangladesh, Côte d’Ivoire, Democratic Republic of Congo, India, 
Indonesia, Myanmar, Nigeria, Nepal, Philippines and the United Republic of 
Tanzania[3]. 
 
Figure 2: Map from World Health Organization showing lymphatic filariasis endemic 
countries and territories.[46] 
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 Socioeconomic impact 
 LF and Onchocerciasis have together resulted in the loss of 5.7 million disability 
adjusted life years [47]. More than $1 billion in lost productivity each year is observed in 
India due to lymphatic filariasis whereas another $1 billion for endemic foci in the 
continent of Africa [48].  A study in rural India of male-weavers afflicted with LF reported 
a greater than 27.4% productivity loss [49].  Apart from the economic burden, an 
individual affected with LF faces social stigma, psychological problems, fear and 
embarrassment [50]. Often suicidal cases, broken marriages due to lack of physical 
intimacy are reported [50]. More than 40 million demonstrate deformities leading to 
social stigma and massive economic loss [3].  
 
 Efforts in controlling LF globally 
 Despite promising research and valid targets, an anti-filarial vaccine is yet to be 
launched for global use [51-56]. Vector control has been conducted in areas where 
malarial and filarial infections are co-endemic. These methods prove beneficial for 
geographically isolated areas. A good example of this would be Solomon Islands. 
Vector control strategies have reduced the prevalence of filarial infection to less than 
2% [57, 58]. Unfortunately, vector control programs are very expensive and labor 
intensive [57]. Insecticide resistance, adverse reactions to insecticides, lack of 
infrastructure to conduct the programs still pose a challenges to implement the 
programs in a third world countries [59]. Chemotherapeutic intervention along with 
vector control serves as a better strategy and play an integral role in filariasis prevention 
and control[55, 60].  
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 Global Program for the Elimination of Lymphatic Filariasis (GPELF): 
success and complications 
The Global Program for the Elimination of Lymphatic Filariasis (GPELF) was 
launched in the year 2000 with an ambitious goal to decrease the incidence and 
prevalence of lymphatic filariasis and eventually eliminate the disease. During the initial 
years, approximately 570 million people were at risk of the disease [61]. China and 
South Korea have eliminated lymphatic filariasis in the year 2007 and 2008, 
respectively. Out of the total 72 participating countries, 68 countries have completed 
mapping their endemic foci, 11 countries have made progress and 2 have yet to start 
the process [3]. The total number of population treated under MDA has increased from 
2.9 million in the year 2000 to more than 500 million in the year 2010. A total of 17 
countries out of the 53 countries have already completed five or more rounds with 100% 
of geographical coverage [3]. 
 
 Despite a huge success of the GPELF program, no convincing evidence has 
been produced to demonstrate that the ultimate goal to eliminate lymphatic filariasis is 
achievable [62]. Patient compliance and cooperation from the governments pose 
significant challenge for success of the GPELF program. Further challenges to the 
GPELF include natural disasters and political unrest, which force populations to migrate 
to non-MDA covered zones, disrupting the therapy.  
 
 Chemotherapeutic agents 
Prior to GPELF, diethylcarbamazine (DEC) was distributed to mass populations 
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as a 0.1- 0.4% fortified salt [63]. This strategy has been used primarily in China, Taiwan, 
India and Brazil [64, 65]. DEC is primarily used in LF mono-endemic area [66]. It is 
contraindicated for its use in areas co-endemic with Onchocerca volvulus as it can 
cause severe ocular and systemic complications in individuals infected with this parasite 
[67]. Similarly, Ivermectin is contraindicated in areas that show prevalence Loa loa 
infections due to severe and fatal adverse effects in L. loa infected individuals [68]. 
Albendazole is used by the GPELF to replace DEC and ivermectin is areas where these 
drugs are contra-indicated. [69]. Currently, GPELF is providing mass drug 
administration programs (MDA) in the endemic countries with donated drugs from 
GlaxoSmithKline and Merck & Co. Inc. More than 52 nations have adopted the MDA 
strategy to combat lymphatic filariasis. Depending upon the endemicity of the infection, 
DEC and Ivermectin are given along with albendazole.  Monotherapy with albendazole 
does not have much effect on the microfilarial load in the blood. When given in 
conjunction with DEC or IVR, albendazole seems to have a synergistic effect. More than 
3.4 billion treatments were delivered to more than 900 million of individuals in 53 
countries between 2000- 2010 [3]. 
 
 Problems with current therapy 
The backbone of the current MDA programs is formed by DEC and Ivermectin, 
the only two drugs approved for human therapy. These drugs are potent microfilaricidal 
but exhibit little effect on adult worms.  Little evidence is available showing the efficacy 
of DEC against adult worms, with most studies suggesting an maximal effect of killing 
40% adult worms.  But treatment alone with DEC is insufficient to cure an individual [62, 
! 11 
70, 71]. Ivermectin act on the glutamate gated chloride channels in free-living 
nematodes [72].  But in culture, Ivermectin shows little to no effect on microfilariae [16]. 
The pharmacological basis of microfilaricidal effect of both DEC is yet to be resolved.  
 
Brief Overview of the Ecdysone Receptor 
 Ecdysteroids 
 Ecdysteroids (a term first coined by Goodwin and colleagues in 1978[73]) are the 
best characterized and most understood insect hormones. The first ecdysone hormone 
identified was α-ecdysone (now called ecdysone) and the second was β-ecdysone (now 
commonly called 20-hydroxyecdysone)[74]. Ecdysone was the first insect hormone to 
be isolated and first appeared in an article in June 1954 [75]. Ecdysteroids were initially 
identified as the molting hormones. Later on, much evidence was provided to proving 
their involvement in other developmental processes. In some insects, ecdysteroids 
induce vitellogenin synthesis that aids formation of oocyte. Ecdysteroids modulate and 
choreograph each molt cycle from early embryogenesis through metamorphosis. 
Ecdysone is produced by the prothoracic gland and gets converted into 20HE in 
peripheral tissues [76]. 20HE is the molecule responsible for controlling apolysis of old 
cuticle and deposition of new cuticle in insects [77]. It also stimulates embryological 
events in the female insect irrespective to the cuticle synthesis [74]. Ecdysteroids have 
found to modulate molting in all the species of insects, whether they undergo complete 
metamorphosis (such as moths and flies) or undergo incomplete metamorphosis (such 
as locusts) [74]. To date, more than 500 unique ecdysteroids have been identified from 
plant and animal sources. 20HE has also been identified in non-arthropod invertebrates 
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the nematodes, mollusks and annelids [78].  
 
 Ecdysone receptor 
 The ecdysone receptor (EcR) belongs to the nuclear receptor (NHR) super 
family[79]. All members of the NHR family share similar modular structure with 
functionally distinct domains[80]. The N-terminal A/B domain followed by the DNA-
binding C domain, the hinge D domain and the ligand-binding EF domain at the C-
terminal end of the protein 
as shown in Figure 1.3[80, 
81]. The E/F domain is 
multi-functional, responsible for ligand binding, ligand dependent transactivation and 
dimerization. The C domain functions as a ligand independent DNA binding domain 
[81]. This domain dictates the specificity of the response elements. The ecdysone 
receptor dimerizes with USP (ultraspiracle) or RXR (Retinoic X receptor vertebrate 
ortholog of USP) and binds with very specific ecdysone receptor response elements 
(EcREs). The response elements are short DNA sequences, usually 5-20 bp in length, 
within the promoter of the gene that has the capability of binding their specific hormone 
receptor and regulate their transcription [82]. In Drosophila melanogaster the promoters 
of several transciptional regulators including E75A, BHR3-B, EcR-B1 contains EcREs 
that are recognized by the activated EcR [83].  Binding of the EcR to these promoters 
activates their transcription, leading to activation of many downstream genes, the so 
called “ecdysone cascade”.  
 
!
Figure 1.3: Nuclear receptor structure with distinct domains.!
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 The ligand-binding domain of the EcR is the central unit of any ecdysone 
controlled gene switch. The ligand-binding domain of the ecdysone receptor has two 
formative characteristics; instability and adaptability of structure. The α-helices 3, 5, 7, 
11 and 12 and the β-sheet provide the receptor an apo-conformation, a remarkable 
capability to bind different types of ligands [84]. Hence, this explains presence of more 
than 500 ecdysteroids in nature.  
 
 Role of ecdysone receptor in insects ! Holometabolous insects like Drosophila melanogaster undergo a complete 
metamorphological transformation from a crawling larva to an adult capable of flight and 
reproduction [85, 86]. This developmental pathway is controlled by a balance of the 
ecdysteroids and juvenile hormones, with the ecdysteroids stimulating and the juvenile 
hormones repressing molting [87, 88]. There are carefully timed spurts of 20HE release 
during the larval molts, pupariation, pupation and transformation in adults. The release 
of 20HE is choreographed by prothoracicotropic hormone, which is produced by four 
dorsolateral neurosecretory cells of brain [89-91]. Pulses of 20 HE trigger pre-pupal 
development forming a puparium. The larval midgut and anterior muscles are destroyed 
in response to 20HE, while the imaginal discs evert to form the rudimentary structures 
corresponding to the adult fly [88, 92, 93]. Within 10-12 hours, another pulse of 20HE 
triggers pre-pupal to pupal transformations. Following apoptotic changes, adult head, 
body, legs and wings emerge.   
Ecdysteroids bind to the EcR-USP heterodimer, which then migrates to the 
nucleus and activates transcription of a cascade of "early genes", "early-late genes", 
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and "late genes" in an autoregulatory loop [94]. 20HE can bind to the ligand-binding 
domain on its own, but the binding is greatly stimulated by the presence of USP [89, 
95]. The early genes Broad- Complex (BR-C), E74, and E75 also belong to the NHR 
family, although most of them are orphan receptors. Studies have demonstrated that 
E75 and BR-C genes are essential for the appropriate development response on 
stimulus with 20HE[88].  
 Ecdysone receptor in gene switching 
 The Ecdysone receptor and ecdysteroids have been known to modulate molting 
and developmental changes in insects. Their natural absence in vertebrate makes them 
an excellent target for gene switch applications due to less possibility of pleotropic 
effects [81, 96]. The theory behind gene switching is that the hormone receptor binds 
with a short DNA sequence in the promoter region of a gene turning its transcription ON 
or OFF, depending upon binding of a ligand. The ecdysone receptor has been 
extensively used as a gene switch to regulate expression of key genes that regulate 
molting and metamorphosis. Studies have shown an ecdysone inducible gene 
expression of the EcR of Drosophila melanogaster in a mammalian cell line [97]. Non-
steroidal agonists come into play as ligands for the gene switch machinery. 
Diacylhydrazines were the first discovered non-steroidal ecdysone receptor analogs in 
1988[78]. Invitrogen marketed the first commercial ecdysone based gene switch. A 
fusion protein of VP16 with Drosophila ECR LBD with a CMV promoter and a complete 
human RXR with a RBS promoter were created. The reporter gene was cloned under 
the control of heat shock protein (HSP) minimal promoter and 5XE/GRE and 3X SP1 
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response elements. The plasmids were transfected in a RXR deficient cell line and 
treated with Ponasterone A to induce the system. A successful gene switch was created 
ready to identify ligands binding with the active site of EcRLBD[81]. Tebufenozide was 
one of the first non-steroidal compounds that gave high transactivation of the reporter 
genes through Bombyx mori EcR [98, 99]. To improve the functionality of the ecdysone 
based gene switch, a two-hybrid format of gene switch was formulated. The GAL4 DBD 
fused with EcR LBD and VP16 fused with RXR constructs under the control of SV40 
promoter with firefly luciferase promoter gene was transfected in a EXR deficient cell 
line[100]. This system has been extensively used for ecdysone based gene switches.  
 The first successful use of ecdysone analog for insect control was reported in 
1980s with the discovery of diacylhydrazines. This class of compounds induces 
precocious molting of larva in susceptible species [101]. The narrow window of activity 
against a specific pest species makes it an excellent tool for pest management. 
Tebufenozide has insecticidal activity against lepidopteran pests but shows no activity 
against the hymenopteran insects. Tebufenozide, Methoxyfenozide, Halofenozide and 
Chromafenozide are the four commercially available insecticides for lepidopteran and 
coleopteran control [81]. In a bioassay, the tetrahydroquinolone family have shown high 
activity against A. aegypti [102].  
 Transgenic plants have also been produced using the gene switch technology. 
The first ecdysone based gene switch was developed in 1999 [81, 103]. Transgenic 
tabacco plants were created that were dependant on tebufenozide induced expression 
of a reporter gene regulated by this EcR-based gene switch [103]. However, the 
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continuous need of a ligand to activate the gene switch and background activity of the 
gene switch limited the use of this technology in the agricultural industry.  
Ecdysone Receptor in Nematodes 
 Nematodes are theorized to be ecdysozoans due to primacy of molting in their 
development.  Homologues of the EcR and analogs many of the downstream genes 
activated by the EcR have been identified in the filarial parasites [104]. Surprisingly, the 
ecdysone receptor and its dimerizing partner RXR are absent in C.elegans [104]. 
Molting in C.elegans is controlled by a different set of nuclear receptors including NHR-
25, 41, 67. These coincide with the homologs of the downstream genes activated in the 
insects [104]. However, control of molting in the filaria remains a relatively unknown 
topic, and the genes participating in the molting cascade are yet to be identified.  Low 
concentrations of ecdysteroids have induced molting of Nematospiroides dubius [105] 
and Ascaris suum [106]. Successful artificial molting has been also been induced with 
ecdysone analogs including 20HE and RH5849 in D.immitis culture [107-109]. In some 
nematodes such as with Meloidogyne javanica, 20HE has caused mortality of the 
organism without inducing any morphological or molting changes [110, 111]. High molar 
concentrations (4.2 to 8.4mM) of 20HE have reported to inhibit development from eggs 
to larval stages and death of the H. contortus within a week [110].  
 
Brugia malayi Ecdysone Receptor 
 The ecdysone receptor and the RXR homologs have been identified in the B. 
malayi and O. volvulus [104]. The ecdysone receptor is expressed in B. malayi in L1, 
! 17 
L2, L3, adult males and females, while the B. malayi RXR homologe is expressed 
predominantly in L1, adult males and females [109]. Brugia malayi EcR, when partnered 
with the Aedes aegypti USP (AaUSP) displayed binding with a synthetic palindromic 
ecdysone response element (EcRE), PAL-1[104]. The protein encoding the ecdysone 
receptor is shown to dimerize with native Brugia RXR as well as RXR from other 
organisms. This indicates the ecdysone receptor of Brugia malayi exhibits behavior 
similar to the insect EcRs. Furthrmore, an ecdysone response element (EcRE) inserted 
in a synthetic Brugia malayi promoter was induced by 20HE in transiently transfected 
Brugia embryos [109]. Together, these studies suggest an existence of a functional 
ecdysone-signaling pathway in the B. malayi.  
Objective 
 Previous research provides substantial evidence of a functional ecdysone 
signaling system in Brugia malayi. Yet, the role played by ecdysone on embryogenesis 
and molting is unclear. This research attempts to further investigate the physiological 
role and chemotherapeutic potential of the ecdysone receptor in Brugia malayi. The first 
part of the study aims on examining phenotypic and biochemical changes on adult 
female worms in presence of 20HE.  Transcriptomic and proteomic studies were 
performed to observe differential gene expression in the treated adult female worms. 
The second part of the study focused on the phenotypic study conducted in-vivo and the 
chemotherapeutic potential of the Brugia ecdysone receptor. A homology model of the 
EcR was developed to provide insights about the ligand-receptor interaction.  
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CHAPTER TWO 
 
PHENOTYPIC AND MOLECULAR ANALYSIS OF THE EFFECT OF  
20-HYDROXYECDYSONE ON THE HUMAN FILARIAL PARASITE BRUGIA MALAYI 
 
 
Abstract 
 A homologue of the ecdysone receptor has been identified and shown to be 
responsive to 20-hydroxyecdysone in Brugia malayi.  However, the role that this master 
regulator of insect development plays in filarial nematodes has not been delineated. 
Gravid adult female B. malayi cultured in the presence of 20-hydroxyecdysone 
produced significantly more microfilariae and abortive immature progeny than control 
worms, implicating the ecdysone receptor in regulation of microfilarial development. 
Only one adult female worm was recovered on stimulating the ecdysone receptor of the 
L3 larvae infected intraperitoneally in an in-vivo gerbil model. This deduced that 
ecdysone receptor causes premature molting leading to the death of the parasite. 
Transcriptome analyses identified 30 genes whose expression were significantly up-
regulated in 20-hydroxyecdysone treated parasites compared to untreated controls.  Of 
these, 18% were identified to be involved in regulating transcription. RNAi phenotype of 
the C.elegans orthologs of the up-regulated genes demonstrated that the 20-
hydroxyecdysone exclusively regulated embryological events. A comparative proteomic
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analysis revealed 932 proteins to be present in greater amounts in extracts of 20-
hydroxyecdysone treated adult females than in extracts prepared from worms cultured 
in the absence of the hormone.  Of the proteins exhibiting a greater than two fold 
difference in the 20-hydroxyecdysone treated versus untreated parasites, 16% were 
involved in transcription regulation. Taken together, the transcriptomic, proteomic and 
phenotypic data suggest that the filarial ecdysone receptor may play a role analogous to 
that in insects, where it serves as a master regulator of development.  
 
Introduction 
Human filarial parasites cause diseases that inflict significant morbidity upon a large 
proportion of the poorest people on the planet[1].  Lymphatic filariasis (caused by 
infection with Brugia malayi, Brugia timori or Wuchereria bancrofti) and onchocerciasis 
(caused by infection with Onchocerca volvulus) result in the loss of 5.7 million disability 
adjusted life years [2]. As a result, these diseases have been identified by the 
international community as two of the five Neglected Tropical Diseases (NTDs) 
worldwide, and both have been targeted for elimination by the international community 
in the London Declaration on Neglected Tropical Diseases [3].   
Elimination programs have targeted both onchocerciasis and filariasis have been 
implemented both at the national and international levels.  All rely primarily upon a 
strategy of mass drug distribution to interrupt transmission and thereby eventually 
locally eliminate the parasite [4].  However, these programs rely upon the small arsenal 
of drugs that must be given over a long period of time (i.e., years).  This leaves the 
programs vulnerable to failure in the face of developing resistance.  Furthermore, the 
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prolonged treatment courses necessary to effect elimination presents substantial 
logistical difficulties resulting from the need to maintain high drug coverage rates over a 
long period of time (i.e. years).  Furthermore, the current drug regimens used by these 
programs face limitations in deployment in many areas.  For example, 
diethylcarbamazine (DEC), a drug commonly used to treat lymphatic filariasis produces 
severe ocular and systemic complications when given to individuals infected with O. 
volvulus [5, 6].  This precludes the use of DEC in much of Africa, where lymphatic 
filariasis and onchocerciasis are co-endemic.  Similarly, treatment of onchocerciasis 
using ivermectin is complicated in areas that are co-endemic for the eye-worm Loa loa, 
as severe adverse events have been documented to occur in individuals treated with 
ivermectin that are heavily infected with L. loa [7].  For these reasons, there is an urgent 
need to develop alternative therapeutic interventions to augment the efforts of the 
elimination programs. 
Ecdysteroids have long been known to play a central role in controlling the development 
of various invertebrates.  They have been best characterized in insects.  These 
hormones exhibit their effects through the activity of ecdysteroid receptors, which act as 
master transcriptional regulators [8, 9]. In insects, the juvenile hormones and ecdysone 
regulate both embryogenesis and the molting cycle. As the juvenile hormones 
decrease, there is a surge in ecdysone levels leading to molting [10].  This effect is 
mediated through a heterodimer of the ecdysone receptor (EcR) and the retinoid X 
receptor (RXR), two members of the nuclear hormone receptor family of transcriptional 
regulators [9, 11, 12].  The fact that molting and the receptors controlling this process 
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are not found in vertebrates makes this process an attractive potential 
chemotherapeutic target.   
A homolog of the ecdysone receptor has been identified and shown to be active in 
Brugia malayi [13].  However, it’s physiological role in controlling the developmental 
processes in this parasite remains unclear [13, 14]. To attempt to decipher the 
physiological role of the Brugia malayi ecdysone receptor (BmEcR), we have conducted 
transcriptomic, proteomic and phenotypic studies of the effect on 20-hydroxyecdysone 
(20HE) on gravid adult female B. malayi.  
 
Materials and Methods 
 Phenotypic studies of the effect of 20-hydroxyecdysone on fecund adult 
female worms 
 Gravid adult female parasites were obtained from the Filariasis Research 
Reagent Resource Center (FR3) at the University of Georgia, USA. A total of 5 worms 
per well were cultured in a 6-well plate using 3ml of CF-RPMI media (RPMI 1640 
supplemented with 25 mM HEPES buffer, 2 mM glutamine, 100 U/ml streptomycin, 100 
µg/ml penicillin, 0.25 µg/ml of amphotericin B, and 10% heat-inactivated fetal calf 
serum). Experiments were designed to consist of two biological replicates of parasites 
treated with 20HE and associated control cultures.  When the parasites were received, 
they were allowed to acclimatize and monitored for any decrease in motility for 24 hours 
(day 0). 20HE was added in the media of the two experimental wells at a concentration 
of 10µM on day 1. Control wells received ethanol (the vehicle of 20HE). Media (either 
containing or lacking 20HE) was changed every 24 hours, and the parasites cultured for 
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an additional three days (days 2-4).  Three aliquots of 20µl or media were removed from 
each biological replicate every 24 hours and the life stages released into media were 
counted, resulting in three technical replicates for each biological replicate for each time 
point. The life stages observed were counted and classified as microfilariae, pre-
microfilariae or eggs/embryos.  
 
 Ethics statement 
 All animal work was conducted according to relevant national and international 
guidelines outlined by the National Institutes of Health Office of Laboratory Animal 
Welfare, and was approved under USF IACUC protocol ID: IS00000261 
 
 Phenotypic study in gerbils 
 The phenotypic study was conducted for 150 days with four male Mongolian 
gerbils maintained in the animal facility at USF under IACUC guidelines. Brugia malayi 
infective larva (L3) was obtained from the Filariasis Research Reagent Resource Center 
(FR3) at the University of Georgia, USA. Each animal was infected intraperitoneally with 
150 L3s under aseptic condition. A total of two experimental animals received 20-
hydroxyecdysone (Adipogen, CA) at a dose of 5mg/kg/day/animal for 150 days. The 
remaining two control animals received ethanol, the vehicle used for delivering 20HE. 
Alzet mini-osmotic pump Model number 2006 was used provide steady supply of 20HE 
for 42 days. The pumps were surgically implanted on the dorsal aspect of the gerbils 
under aseptic conditions two days post-infection. The pumps were replaced every 42 
days as per the manufacturer’s directions. Hence, each animal received total of 4 
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pumps during the entire study. Peritoneal gavage with 2ml warm and sterile RPMI was 
performed at 110th day to establish the status of the infection. Animals were euthanized 
after 150 days post-infection according to IACUC standards using CO2 gas. Peritoneal 
gavage was performed to recover microfilariae. Necropsy was conducted to recover 
adult worms from the peritoneal cavity.  
 
 RNA Extraction  
 Fecund adult females, cultured as described above, were used to prepare RNA 
for the transcriptome analysis.  Total RNA was isolated from the two biological 
replicates of 5 worms each (2 wells each of treated and untreated parasites) after 2 
days culture with and without 20HE. The worms were flash frozen in liquid nitrogen. 
RNA was extracted from the worms using Trizol LS (Invitrogen, Carlsbad, CA)[15, 16].  
The biological replicates of the induced and uninduced samples were lysed individually 
using TissueLyse II (Qiagen, Valencia, CA) followed by chloroform extraction, 
isopropanol precipitation and elution in 0.1xTE (1X TE = 10mM Tris-HCl, pH 8.0, 1mM 
EDTA). The samples were treated with DNase I (Ambion, Austin, TX) according to the 
manufacturer's instructions. The RNAs were subjected to drop dialysis using 45nm 
Millipore membranes (EMD Millipore, Billerica, MA) against 0.1 X TE buffer at 4°C for 2 
– 4 hours and the RNA then collected from the membranes. The purity of the samples 
was assessed using a using NanoDrop apparatus  (Thermo Scientific, Waltham, MA). 
The quantity of the RNA was determined using a Qubit apparatus (Life Technologies, 
Carlsbad, CA). The purified RNA was stored at -80°C.  
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 RNA Library preparation 
 The NEBNext poly(A) mRNA Magnetic Isolation Module (NEB # E7490) was 
used to isolate intact poly(A)+ RNA from each previously isolated total RNA. The eluted 
RNA was used for first and second strand cDNA synthesis using NEBNext Ultra RNA 
Library Prep Kit for Illumina (NEB # E7530). The double stranded cDNA was size 
selected and the fractions between 250-550 bp were isolated using 1.8x Agencourt 
AMPure XP beads. End repair and dA tailing of cDNA library was performed, 
immediately followed by adaptor ligation.  NEBNext Multiplex Oligos for illumina were 
used for adaptor ligation. The cDNA libraries were PCR amplified and purified. Quality 
control was performed using a Bioanalyzer (Agilent, Santa Clara, CA) to analyze the 
quality and size selection of the cDNA. The samples were again subjected to Qubit to 
quantity the yield of cDNA.  
 
 Transcriptome Sequencing 
 RNAseq was performed on Illumina MiSeq at the Core facility, Smith College, as 
part of the FR3 (Filarial Reagent Resource Repository), following the manufacturer’s 
protocol. In brief, the cDNA library (at a concentration of 4nM) was denatured using 
0.2N sodium hydroxide. The library was diluted to 20pM in Illuminia hybridization buffer, 
and the template strands hybridized to the adaptors attached to the flowcell surface as 
previously described [15]. The library was diluted to 9pM with Illumina HT1 buffer. The 
PhiX control was used as an internal standard. The PhiX standards were denatured and 
diluted using the same protocol as the sample library. The libraries were heated at 96oC 
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for 2 minutes, followed by immediate cooling. Samples were loaded into an Illumina 
cartridge and single-end reads produced.   
 
 Data analysis 
 The Tuxedo suite of programs was used to process and analyze the data [17].  
Bowtie2 was used to build indexes of the B. malayi reference genome from WormBase 
(v. WS245)[18]. RNA-Seq reads from each sample were aligned to the B. malayi 
genome using TopHat (v. 1.4.1)[19].  A maximum of one mismatch per read was 
allowed.  The mapped reads from TopHat were used to assemble known transcripts 
from the reference and their abundances were estimated using Cufflinks [20]. Cuffdiff is 
very conservative when identifying differentially expressed genes compared to edgeR 
and DESeq [21]. Thus, edgeR was used to analyze the data using the counts generated 
for the four samples with Cuffdiff. A heatmap was created using Bioconductor 
pheatmaps R software comparing the expression of individual transcripts in the 20HE 
treated and untreated parasites. Gene Ontology (GO) annotations were assigned using 
WormBase (v. WS245)[22]. Orthologs of the differentially expressed genes from the 
transcriptome were identified in the C.elegans genome using WormBase (v WS249). 
RNAi phenotypes of the identified C.elegans orthologs were assigned using the RNAi 
tool available at WormBase. Hypergeometric test was performed to obtain the 
probability of occurrence of the RNAi phenotype in C.elegans genomes as compared to 
dataset.  
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 Real-Time PCR Validation 
 Selected genes were chosen based on the GO annotations for real time PCR 
validation as depicted in Additional file 1 Table 2.1. The gene encoding NADH 
dehydrogenase subunit 4 (ND4) was utilized as an internal control, as it’s expression 
was equivalent in 20HE induced and control parasites, based upon the transcriptome 
analysis described above. Three independent biological replicates of control and 20HE 
treated parasites were prepared as described above. Total RNA was extracted from 
each replica using the protocol described above. Primers for qRT-PCR were designed 
to span the exon-intron boundaries, eliminating the possibility of amplification of 
contaminating genomic DNA in the sample [23]. The primers and probes used for the 
study are shown in appendix for chapter 1 Table 1. SuperScript® III One-Step RT-PCR 
System with Platinum® Taq DNA Polymerase (Life Technologies, Carlsbad, CA) was 
used in the amplification reactions, using the conditions provided by the manufacturer.  
Taqman chemistry was applied using iTaq Universal Probes One-Step Kit (Biorad, 
Hercules, CA) for the real time PCR.  The efficiency of the PCR reactions using these 
conditions was calculated to be 95%. Each biological replicate was analyzed using 
triplicate technical replicates. Relative quantification of starting mRNA copy number in 
each samples was calculated using the ΔΔCt method.  
 
 Preparation of protein extracts 
 Adult female worms cultured in the presence and absence of 20HE as described 
above were homogenized in 150µl of a buffer containing 125mM Tris-HCl (pH 8.5), 4 % 
SDS 0.5mM PMSF and 100mM DTT. A total of three biological replicates of 20HE 
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treated and untreated worms were used for the study. Protein concentrations were 
determined using the Pierce 660 nm Protein Assay supplemented with Ionic Detergent 
Compatibility Reagent supplementation (Pierce). The samples were processed using 
Filter-aided sample preparation (FASP) for mass spectroscopy (MS) based proteomic 
analysis. Raw MS files were processed with MaxQuant with a 1% FDR (False Detection 
Rate). The normalized ratios of each biological replicate obtained from the MaxQuant 
analysis were input into the Perseus processing suite [24]. An unpaired student’s t-test 
with a significance value of p < 0.05 used to test for statistical significance of the 
quantitation. A total of 6050 proteins were detected, which included multiple isoforms. 
Proteins with multiple isoforms were considered as a single entity for further analysis, 
resulting in 3991 unique proteins. An empirical filter of proteins with more than 2 
peptides identified, a p-value less than 0.05 and a greater than 2-fold change was 
applied to the data. The Bonferroni correction was applied to correct the p-value for the 
proteins analyzed. A total of 359 proteins were identified to be significantly more 
abundant in the induced extracts. Gene Ontology (GO) terms were assigned to the 
differentially abundant proteins.  
 
 GO enrichment analysis of the over-represented GO terms 
 GO enrichment analysis for differentially abundant proteins was performed using 
the R software environment. All the proteins (19,681) from WormBase were considered 
as the background list and the differentially abundant proteins identified as described 
above (359) extracted from the proteomics data were considered as the sample list. A 
p-value for each GO term, based on its domain was calculated using the 
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Hypergeometric Test [25].  Enriched GO terms from each domain were sorted based 
upon a p-value of < 0.05. The top GO terms that were significantly over-represented at 
least five times more than the control list in the 20HE treated proteins were identified. 
Graphs were plotted based on ratios of the p-value for the particular GO term and total 
number of unique proteins exhibiting that category. Biological processes incorporated 
200 unique proteins in the ecdysone treated proteome and 1936 in the controls. 
Molecular processes indicated 155 unique proteins in the 20HE treated proteome and 
1620 in the controls. 
 
Results 
 The role of ecdysone receptor as a master regulator of developmental processes 
is well discerned in insects. Previous studies with embryos from adult female worm of 
Brugia malayi provided insights of having a functional ecdysone responsive system in 
culture. To further delineate the role of the ecdysone receptor on the developmental 
process in a vertebrate host, fecund adult female parasites were initially cultured in vitro 
in the presence and absence of 20HE as described in Materials and Methods.  
Parasites cultured in the presence of 20HE exhibited a significant increase (p < 0.001) 
in the production and expulsion of both microfilariae and eggs and embryos when 
compared to control parasites (Figure 2.1).  These data implicated 20HE in the control 
of microfilarial development and embryogenesis, and provided a phenotype that could 
be used to monitor the effect of 20HE in subsequent experiments.  
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 An in-vivo study was conducted to observe molting and embryological changes, 
as described in Materials and Methods. After 150 days, the animals were euthanized 
and the peritoneal cavity was examined for parasites. A total of 25 and 28 adult 
parasites were recovered from the peritoneal cavity of the control animals. In contrast, 
the two experimental animals that received 20HE via Alzet mini-osmotic pumps, no 
parasites were recovered from the first animal whereas a single female was recovered 
from the second animal. A large number of mature microfilariae were recovered from 
the controls whereas no microfilariae were observed in the peritoneal cavity of the 
treated animals. On visual inspection, the adult female parasite recovered from the 
20HE treated animal was shorter in length as compared to the control as shown in 
figure 2.2.  
 
 To identify the genes participating in the ecdysone responsive pathways, female 
B. malayi parasites were cultured in the presence and absence of 20HE and harvested 
after 48 h. This is the time point at which enhanced mf production and expulsion of 
immature stages from the treated worms were at their peak (Figure 2.1).  RNA was then 
prepared from two independent biological replicates and subjected to transcriptome 
analysis.  The biological replicates demonstrated a strong correlation in their Fragments 
Per Kilobase of Transcript per Million Mapped Reads (FPKM) values (Figure 2.3, Panel 
A). Differentially expressed genes were identified using the EdgeR Negative Binomial 
Distribution as having a minimum of a 2 fold change in expression between the control 
and treated worms with a p-value <0.01.  A total of 44 differentially expressed genes 
were identified in the 20HE treated parasites when compared to control parasites 
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cultured in the absence of the hormone; 30 genes were up-regulated and 14 genes 
were down-regulated (Figure 2.3, Panel B).  
 
 Gene Ontology (GO) analysis was performed on the 44 differentially expressed 
genes. The results of this analysis are summarized in Figure 2.4.  A total of 18% of the 
up-regulated genes were involved in regulation of transcription; 11.3 % participated in 
cellular processes and 2.27% were involved in cellular differentiation. Of the 30 up-
regulated genes, a total of 18 orthologs were identified in the C.elegans genome. The 
RNAi profile of these genes revealed that almost all the orthologs exhibited phenotypes 
consistent with an involvement in developmental processes, such as embryonic lethal, 
sterile, reduced brood size, spindle assembly defective early embryos, egg laying 
defective, L1 arrest, larval arrest, larval lethal, asymmetric cell division defective early 
embryogenesis, slow growth, pleiotropic defects, severe early embryos, early embryonic 
lethal and sterile progeny (Table 2.1). The probability of finding embryonic lethal and 
other embryological phenotypes in the dataset was found to be statistically significant (p 
< 0.001) on hypergeometric test.  
 
 To evaluate the quantitative robustness of the transcriptome study, four genes 
were chosen for validation using q-RT-PCR.  These genes were chosen from among 
the transcriptional regulators identified in the GO analysis, and represented a range of 
their predicted up-regulation from 5-fold to 392-fold between the treated and untreated.  
Figure 2.5 shows the fold changes of the three biological replicates of each chosen 
gene as estimated by q-RT-PCR. The degree of up-regulation seen in the q-RT-PCR 
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assays were found to correspond closely to those calculated from the FPKM analysis of 
the transcriptome data in all cases (Table 2.2).   A Pearson correlation coefficient of 
0.99 was observed when the degree of up-regulation observed in the transcriptome and 
qRT-PCR data were compared.  
 
 Although the transcriptome analysis demonstrated excellent reproducibility with 
biological replicates and q-RT-PCR validation, it identified a relatively small number of 
genes whose transcripts were up-regulated in response to 20HE.  However, because 
protein levels may also be regulated through post-transcriptional mechanisms, the effect 
of 20HE on the female proteome was also explored.  To accomplish this, total protein 
extracts from adult 20HE treated worms and control worms were subjected to FASP 
digest and LC/MS/MS spectroscopy, as described in Materials and Methods. A total of 
3,991 unique proteins were identified (Additional file 2, Dataset S1). A total of 359 
unique proteins were found to exhibit a greater than 2 fold-change in abundance in the 
20HE treated parasite extracts when compared to the control worm extracts.  These 
proteins were identified using the annotations provided in WormBase release 240 
(Figure 2.6).  An overlap of 11 genes was observed between the transcriptomic and the 
proteomic data. The majority of the proteins that were more abundant in the 20HE 
extracts had an uncharacterized function.  However, similar to what was seen in the 
transcriptome data, 15% of the more abundant proteins in the 20HE extracts were 
involved in regulation of transcription. Another 4% were involved in signal transduction, 
3% in translation, 3% in chromosomal regulation and cell cycle regulation and 22% in 
cellular processes.  A large number of structural proteins were more abundant in 20HE 
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treated extracts. The other categories that were more abundant in the treated extracts 
included protein kinase activity, tyrosine phosphatase activity, and metal ion binding.  
 
 GO term enrichment analysis was performed on the proteomic data to determine 
the significance of the occurrence of the key GO terms whose members were more 
abundant in the 20HE treated extracts.  The key biological processes that were 
significantly more abundant in the 20HE treated extracts included translation, 
intracellular protein transport, G-protein coupled receptor protein signaling pathways 
(Figure 2.7, Panel A).  Molecular functions like structural constituents of the ribosome, 
protein tyrosine phosphatase activity, structural constituents of the cytoskeleton were 
also identified as more abundant in the treated extracts (Figure 2.7, Panel B).  
 
Discussion 
 The data presented above suggest that the BmEcR may play a role in 
embryogenesis in parasitic nematodes, as has been observed in insects.  Worms 
cultured in the presence of 20HE exhibited an increase in expulsion of microfilariae, pre-
microfilariae and eggs/embryos into the culture medium for two days, followed by a drop 
in the number of progeny expelled in subsequent days.  These data suggest that 20HE 
induced abortion of immature life cycle stages from the gravid females, resulting in a 
depletion of immature parasites from the uterus by the third day in culture.  Although the 
microfilariae expelled into the media in the worms cultured in the presence of 20HE 
appeared morphologically normal, it was not possible to determine if they were reduced 
in their ability to infect mosquitoes, as we found that microfilariae produced by gravid 
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females cultured in the absence of 20HE were also not infectious to mosquitoes.  
Studies measuring the effect of 20HE on infectivity of microfilariae will need to be 
conducted in a system in which the microfilariae produced are normally infectious (e.g., 
in infected animals rather than in culture).  
 
 The role of the ecdysone receptor on molting and embryogenesis is yet to be 
described in the human parasite Brugia malayi. The in-vivo study conducted with L3-
stage larva infected gerbils clearly delineates the role of the ecdysone on molting in the 
host. The implanted parasites failed to develop into adult stage parasites. The effect of 
20HE is hypothesized to have caused precocious molting of the L3stage larva. The 
early molt cycle would have resulted in the death of the organism just like in insects. 
The parasites recovered control animals were morphologically normal and were actively 
producing microfilariae. The alone female recovered from the treated animal show clear 
signs of developmental retardation. The thin body and shorter length provided evidence 
that eternal stimulation with 20HE causes premature molting leading to developmentally 
non-viable parasites. The alone female did not show any expulsion of microfilariae. This 
could be accounted to the fact that there was no male worm to fertilize the eggs. Further 
studies could be performed to observe the effect of 20HE on gerbils with a patent 
infection.   
 
 A total of 44 differentially expressed genes were identified in the ecdysone-
cultured parasites when compared to those cultured in the absence of the hormone. 
Although few mRNAs were identified as regulated by exposure to 20HE, the data were 
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robust showing high correlation between biological replicates. Majority of the genes 
were uncharacterized and unannotated genes. Given the availability of the complete 
genome with complete annotations and RNAi profiles of all the C.elegans genes, 
orthologs of differentially expressed genes of B. malayi were identified in the C.elegans 
genome. As orthologs retain the same functionality during the course of evolution, the 
results derived from analyzing the RNAi phenotype of the C.elegans orthologs could be 
extrapolated to the B. malayi transcriptome. Although few orthologs were identified, 
almost all of the orthologs revealed a solid phenotypic profiles directing towards 
numerous embryological events. The data strongly suggests that silencing these 
particular up-regulated genes can be embryologically detrimental and could lead to 
death of the parasite. The RNAi phenotype analysis supports the theory that ecdysone 
receptor regulates embryological events in the human parasite Brugia malayi.   
 
 To confirm the veracity of the transcriptomic analyses, a series of representative 
genes whose expression levels were changed by exposure to 20HE were examined 
using q-RT-PCR.  The mean fold change of the three biological replicates of all genes 
as measured by q-RT-PCR corresponded closely with the mean FPKM values of 
RNAseq replicates.  This suggested that the FPKM values observed in the 
transcriptome analysis accurately reflected changes in the levels of the various 
transcripts.   
 
 The proteomic data revealed 359 unique proteins whose levels were more 
abundant in parasites exposed to 20HE.  Of these a total of 11 were found to coincide in 
! 44 
the transcriptome and proteome studies. This is similar to other studies in the systems 
biology literature, which have generally observed few proportional correlations between 
transcript and protein expression [26-30]. The differences in the transcriptome and 
proteome datasets could be attributed to different translational efficiencies post-
translational regulation and differential protein stability [29, 31-36].  Despite this lack of 
overlap, the proteomic analysis generally supported the hypothesis derived from the 
transcriptome data that the BmEcR regulated a regulatory cascade.  The proteomic 
study identified a large number of proteins participating in regulation of transcription, 
signal transduction and cellular functions as more abundant in worms exposed to 20HE.  
 
Conclusions 
 In summary, the data presented here demonstrate that 20HE has demonstrable 
effects of gravid adult female B. malayi, at the phenotypic, transcript and protein levels. 
The RNAi phenotypic analysis strongly suggests that the BmEcR playing a role in 
regulating embryonic development in this parasite.  Further studies will be needed to 
elucidate the role that this regulator plays in the other life cycle stages of the parasite.  
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Tables and Figures 
Table 2.1: RNAi phenotype analysis of the B. malayi orthologs in the C.elegans genome.   
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Table 2.2: Comparison of fold change between RNAseq and real time PCR 
Gene ID Putative Functions RNAseq qRT-PCR 
  I/UI I/UI 
Bm58 Signal transduction 8.3 8.4 ± 0.75 
Bm7925 Regulation of transcription 159.9 169 ± 22.8 
Bm12555 Nuclear receptor like gene 5.2 4.7 ± 0.38 
Bm11454 Nematode larval development 
factor 
392 356.5 ± 25.62 
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Figure 2.1: Effect of 20-hydroxyecdysone on the physiological activity of the adult 
female worms in culture: The X-axis shows two biological replicates of the treated and 
controls. The bars depict counts observed. The error bars show the standard deviation 
of the three technical replicates.   
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Figure 2.2: In-vivo phenotypic study demonstrating effect of 20HE on adult 
worms. Panel A: Control worms showing normal length of the adult female worm. Panel 
B: Ecdysone treated worms showing stunted growth and shorter length.  
 
  
!
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Figure 2.3: Transcriptomic analysis of the 20-hydroxyecdysone induced and 
uninduced worms. (A) A heat map from hierarchical clustering of differentially 
expressed genes of the adult female worms induced with 20HE and controls in 
duplicate experiments (N=4). Expression level was coded as red demonstrating up-
regulation and yellow demonstrating down-regulation. (B) The scatter plot shows 
reproducibility of the technical replicate of the induced samples. Expression scores of 
each biological replicate were plotted on a log10 scale and compared with their 
counterparts to find any splicing variant in the specific loci. (C) The scatter plots shows 
reproducibility of technical replicates of the uninduced samples.   
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Figure 2.4: Pie chart of the functions of the differentially expressed up-regulated 
genes: Up-regulated genes were sorted based on the GO classification. 
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Figure 2.5: qRT-PCR validation of the expression level demonstrated by the 
RNAseq:  Columns represent fold inductions in three biological replicates and the error 
bars the standard deviation surrounding the estimates of three technical replicates per 
biological replicate. 
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Figure 2.6: Pie chart of the GO terms of the up-regulated proteins: 359 proteins 
with a greater than 2 peptide match, p-value <0.01 and greater than 2 fold change were 
included.  
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Figure 2.7: Gene Ontology term enrichment analysis of the ecdysone treated 
proteins as compared with the control. (A) Enrichment for GO ‘Biological Process’ 
terms of proteins were detected as more abundant in the induced extracts (dark blue 
bar) as compared to controls (light blue bar) as determined using Hypergeometric test. 
The Y-axis shows the terms that were significantly enriched (p-value <0.01). The X-axis 
displays the fraction relative to all GO Biological Process terms (B) Enrichment for GO 
‘Molecular Function’ main terms of proteins were detected as more abundant in the 
induced extracts (dark blue bar) as compared to controls (light blue bar) as determined 
using a Hypergeometric test. The Y-axis shows the terms that were significantly 
enriched (p-value <0.01). The X-axis displays the fraction relative to all GO Molecular 
Process terms. 
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CHAPTER THREE 
 
ECDYSONE RECEPTOR: A NOVEL TARGET FOR DEVELOPMENT OF DRUGS 
AGAINST LYMPHATIC FILARIASIS 
 
 
Abstract 
 A homologue of the ecdysone receptor (EcR), a master regulator of development 
in insects has previously been identified and shown to be responsive to 20HE (20- 
hydroxyecdysone) in transfected B. malayi embryos. As the EcR is not found in 
vertebrate animals, it and the regulatory pathways it controls represent an attractive 
potential chemotherapeutic target. A mammalian two-hybrid system involving BmEcR 
Gal4 and RXR VP16 fusion constructs and a GAL4 Gaussia luciferase reporter was 
used in the transient transfection assay. When bound to a cognate ligand like 20-
hydroxyecdysone, transactivation of the luciferase reporter is observed. A stable cell 
line was created incorporating the three plasmids in the HEK293 cell line genome for 
the development of a high throughput screening assay to identify agonists and 
antagonists of the filarial EcR. The assay was employed to screen steroidal, non-
steroidal and natural ecdysone analogs.  A total of 7 agonists and 2 antagonists have 
been identified. A homology model was created using the BmEcR ligand-binding 
domain for virtual docking studies. The homology model was used to study the ligand-
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receptor interaction of the agonists identified with the molecular assay. An excellent 
correlation between the homology model and the molecular assay was observed. Based 
on both the screening models, the diacylhydrazine family of compounds was identified 
as a fruitful source of potential agonists or antagonists of the receptor. These studies 
should assist in the development of inhibitors for the BmEcR that may be evaluated as 
potential lead compounds for development of a new class of drugs against the filariasis. 
 
Introduction 
 Diseases caused by the human filarial parasitic nematodes are a significant 
public health problem faced by developing countries.  Recent reports estimate that there 
are over 140 million individuals suffering from human filarial parasites in over 80 
countries worldwide. Even larger numbers of individuals (> 1 billion) remain at risk for 
contracting the filarial infections [1]. Lymphatic filariasis (caused by infection with Brugia 
malayi, Brugia timori or Wuchereria bancrofti) and onchocerciasis (caused by infection 
with Onchocerca volvulus) result in severe debilitating diseases together resulting in a 
loss of 5.7 million disability adjusted life years [2]. 
 
 Both lymphatic filariasis (LF) and onchocerciasis have been designated as 
neglected tropical diseases by the international community and both have been targeted 
for elimination in the London Declaration on Neglected Tropical Diseases [3]. The 
efforts to eliminate LF and other NTDs have generally relied on mass drug 
administration (MDA) programs. Though MDA programs have on the whole been well 
formulated and executed, they face potential challenges that may threaten their ultimate 
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success.  These include the development of resistance to the limited number of drugs 
that are deployed by the MDA program [4] and local clinical limits on the use of MDA in 
certain areas.  For example, diethylcarbamazine (DEC) is used to treat LF by MDA 
programs throughout India, South America and Southeast Asia [5, 6].  However it 
cannot be used in Africa, as it causes severe ocular side effects and systemic 
complications in individuals co-infected with O. volvulus, the causative agent of 
onchocerciasis, a disease that is endemic throughout most of sub-Saharan Africa [7, 8].  
Similarly, ivermectin, which is the only drug used by the MDA programs worldwide to 
treat onchocerciasis, cannot be easily used in much of Central Africa.   This area is 
endemic for the eyeworm Loa loa, and treatment of L. loa infected individuals with 
ivermectin can result in to severe neurological reactions, including coma and death [9]. 
Thus, new and diversified treatments are desperately needed to treat these infections. 
 
 Ecdysteroids are master regulators of development in insects, and are thought to 
also play a central role in controlling development in other organisms in which molting is 
a central feature of the life cycle (the ecdysozoans)[10].  In insects, molting and other 
developmental processes (including embryogenesis) are controlled through variation in 
the levels of the molting hormones, or ecdysteroids, which induce molting and the 
juvenile hormones, which inhibit molting [11, 12].  This process is mediated through a 
heterodimer of the ecdysone receptor (EcR) and the retinoid X receptor (RXR), which 
controls the transcriptional activity of the developmental genes regulating ecdysis [13].  
The fact that ecdysis is the central developmental pathway in insects and is a pathway 
totally lacking in vertebrates has made it an attractive target for the development of 
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compounds that might act selectively against invertebrates [14, 15].  Thus, the 
agricultural industry has targeted the EcR in pesticide development in the past, as 
insects represent one of the largest classes of ecdysozoans on Earth.  The narrow 
window of activity against a specific pest species makes it an excellent target for pest 
management agents. For example, tebufenozide has insecticidal activity against 
lepidopteran pests but shows no activity against the hymenopteran insects [15].  
 
 A homolog of the EcR has been identified and proven to be functional in Brugia 
malayi [10, 16].  Homologues of the EcR have also been identified in the genomes of 
other human filarial parasites. The physiological role played by ecdysone receptor 
remains unknown.  However previous studies have demonstrated that treatment of the 
filaria with ecdysteroids can affect embryogenesis [16], molting[17] and viability of adult 
parasites, suggesting that the EcR might represent an attractive chemotherapeutic 
target against these infections.  In this study, we report progress towards the 
development of a high throughput screening assay to identify agonists and antagonists 
against the BmEcR, the results of a preliminary screen of known steroidal analogs 
active against other members of the NHR family, and the development of a homology 
model of the BmEcR that will be useful in conducting in-silico screens for agonists and 
antagonists of the BmEcr and in optimizing leads identified by high throughput and in-
silico approaches.   
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Materials and Methods 
 Transient transfection of HEK293 cells 
 Previous studies utilized a system in which plasmids were transiently transfected 
into NIH3T3 cells [10].  However, in these studies the plasmids were transfected into 
HEK293 cells due improved growth and enhanced assay characteristics when these 
cells were used. The cells were grown in 1x MEM (Cellgro, MA) growth media fortified 
with 10% heat inactivated fetal bovine serum (Atlanta Biologicals, GA), and 1% 
Penicillin-Streptomycin (100x stock from Thermo-Fisher, MA). The cells were 
maintained in tissue culture treated T75 flasks (Corning Inc, NY) at 37oC and 5% CO2. 
Transient transfection studies utilized previously described constructs [3] consisting of 
three plasmids:  1. A plasmid encoding the ligand binding domain (LBD) of the BmEcR 
fused to the GAL4 DNA binding domain at a concentration of 150ng/well; 2.   A plasmid 
encoding a dimerization partner consisting of the human RXR chimera fused to the 
VP16 activation domain at a concentration of 100ng/well; and 3.  A reporter construct 
containing a minimal promoter, a GAL4 activation domain, and five copies of the 
ecdysone response element driving the transcription of a secreted Gaussia princeps 
luciferase open reading frame at a concentration of 150ng/well [10]. The plasmids were 
chemically transfected in the cells using the Lipofectamine® LTX and Plus™ reagent 
(Invitrogen, CA). DNA-lipid complexes were formed by incubating the three plasmids (at 
the above concentrations) with 1.5ul of LTX reagent per well and 0.5ul of Plus reagent 
per well at room temperature for 20 minutes. In brief, 50,000 cells were seeded in each 
well of a standard 96 well tissue culture plate (Costar, Sigma-Aldrich, MO). The plate 
was incubated for 18-24 hours. When the cells reached an optimum density of 70-90%, 
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the DNA-lipid complex was added to each well. The cells were further incubated for 24 
hours and 20HE dissolved in ethanol (vehicle) was added at a final concentration of 
10uM to half the wells. The other half of the wells received ethanol alone. The plate was 
incubated at 37oC under 5% CO2 for an additional for 48 hours.  A total of 10ul of the 
supernatant culture media was removed from each well and assayed for the presence 
of Gaussia secreted luciferase using the Dual Luciferase assay kit (Promega, WI) and 
measuring absorbance for renilla luciferase at 480nm wavelength as following the 
manufacturer’s protocol.  Z’ values for the assay were calculated using the formula [18]. 
!! = 1− 3 !" + !!"!" − !!"  
 Constructs for creating stable cell line 
 To adapt the transient transfection assay into a high throughput screen, a stable 
mammalian cell line was developed, in which all three of the necessary constructs were 
integrated into the mammalian genome, employing the Gateway recombination system 
(Invitrogen, CA).  In brief, three cassettes were constructed.  The first cassette 
consisted of the LBD of the BmEcR fused to a heterologous GAL4 DNA binding domain. 
This fusion ORF was placed under the control of the CMV intermediate early promoter 
and terminated with an Sv40 poly-A addition signal.  The second cassette contained the 
ORF for the human RXR chimera fused to the VP16 activation domain.  This chimeric 
ORF was placed under the control of the SV40 promoter and terminated with the bovine 
growth hormone poly-A addition signal.  Finally, the Gaussia princeps secreted 
luciferase reporter ORF was flanked by a GAL4 response element, five copies of the 
ecdysone response element and a minimal promoter. The reporter ORF was terminated 
with the human B globin poly-A addition signal. All cassettes were prepared using 
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standard molecular cloning procedures and amplified by PCR with appropriate primers 
to produce products ready for recombination cloning.  The three cassettes were then 
cloned by recombination into three pDONR vectors of the multisite Gateway Pro system 
(Figure 3.1). The sequence of the resulting entry clones were confirmed and the 
functionality of the entry clones confirmed by transiently transfecting all three into 
HEK293 cells and testing for reporter activity in cells cultured in the presence and 
absence of 20HE, as described above.  The entry vectors were then inserted by three-
way recombination into the destination vector pJTI Fast Dest (Invitrogen, CA) to create 
a destination vector containing all three cassettes (Figure 3.1).  This construct was 
validated by DNA sequencing and by functional assays, as described above.  The 
destination vector was then used to create a stable mammalian cell line in HEK293 
cells, using the Jump In Fast Gateway Targeted Integration System (Invitrogen, CA).  
Clones were selected in the presence of 30ug/mL hygromycin, following the 
manufacturer’s protocol, and individual clones selected and screened for reporter 
expression in the presence and absence of 20HE, in order to identify the clone 
producing the greatest signal to noise ratio and minimal well-to-well variation. The clone 
that exhibited highest signal to noise ratio was cultured and maintained in T75 flasks 
using 1x MEM media fortified with 10% FBS.  
 
 Screening strategy and screening of ecdysone analogs 
Thirty-five thousand seeded cells of the cell line developed as described above were 
seeded into each well of a 96 well tissue culture plate. The cells were grown under the 
same conditions as mentioned above. Cells were incubated at 37°C for 18-24 hours 
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until they reach optimum density of 70-90%. Compounds were added to wells 
containing the cells at a concentration of 10uM and the cells incubated in the presence 
of the compounds for 48 hours.  Control wells received ethanol, the vehicle of 20HE. A 
total of 10ul of the culture media was removed from each well and assayed for secreted 
luciferase activity as described above. 
 
  The strategy for assaying for agonist and antagonist activity against the BmEcR 
is summarized in Figure 3.2.  In brief, each compound was assayed in triplicate in cells 
that were incubated in the presence or absence of 10uM 20HE.  Compounds were 
considered to have agonist activity if they resulted in a significant increase in reporter 
activity when added to cultures of the stable reporter cells cultured in the absence of 20- 
HE.  They were considered to have antagonist activity if they resulted in a significant 
decrease in reporter activity when added to cultures of cells that were already cultured 
in the presence of 20HE.  The student t-test was used to calculate the significance of 
any agonist or antagonist activity observed, and the Bonferroni correction was applied 
to the results to correct for multiple comparisons. The compounds that resulted in a 
statistically significant increase or decrease in reporter activity (p < 0.05, Bonferroni 
corrected) were further cultured with the cells in the ten-fold serial dilutions in triplicate 
format to calculate EC50 values. To assess cytotoxic effects of the compounds on the 
mammalian cell line, cell viability was assayed with Alamar Blue (Thermo-Fisher 
Scientific, MA) according to manufacturers protocol 
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 Homology model construction, validation and refinement 
 Figure 3.3 presents the pipeline used to generate the homology model.  The 
tertiary structure of the BmEcR was predicted using the Schrödinger’s Prime 3.1 
comparative homology modeling module (Prime. Schrodingers, LLC New York, NY 
version 3. ed. 2012). Due to the lack of experimental crystal structure, a search for 
suitable template structures upon which to model the BmEcR was undertaken using 
BLAST  (basic local alignment search tool)[19].   The hemipterin Bemisia tabaci, EcR 
(PDB ID: 1Z5X) was predicted to be the best template homolog of BmEcR (BLAST-bit 
score: 145.2).  Based on the template secondary structure, Clustalω [20] was used to 
optimize the placement of BmEcR LBD α-helices and β-sheets using a hidden Markov 
model (HMM). After the Clustalω alignment studies, backbone atoms for aligned regions 
and conserved residue side chain atoms were directly transferred from the template to 
the query sequence to create an initial structure, followed by adding insertions and 
closing gaps using a knowledge based approach. The B. tabaci EcR native substrate 
ponesterone A was retained in the binding site during the homology model construction. 
The prime serial loop sampling protocol was used to refine one particular loop of 
importance (residues 162-175) that constitutes part of the binding site. To alleviate 
possible steric clashes between residues after model construction, Truncated Newton 
Conjugate Gradient (TNCG) minimization was performed in implicit solvent (VSGB 2.0) 
with OPLS-2005 force-fields, until convergence was reached (< 0.01 kcal.mol-1 Å-1)[21].  
The homology model was validated by generating Ramachandran plots and compared 
to the homology model generated using I-Tasser web-server (details in supplemental 
material) for structural validation [22]. To further improve the quality of homology model, 
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Molecular Dynamic (MD) simulations were performed for 65 ns evaluating structural 
properties such as radius of gyration (Rg), root mean square deviation (RMSD), root 
mean square fluctuation (RMSF) and total energy of the system (details in supplemental 
material). A representative structure was generated by choosing the compound with the 
lowest interaction energy from the highly populated clusters for performing docking 
studies (see supplemental material for details).  
 
 Molecular Docking studies  
 All ligand structures were optimized implementing Schrödinger’s LigPrep 2.3 
module to produce appropriate 3D structures with correct stereochemistry, protonation 
states, and ring conformations. The optimized ligands were then virtually docked in the 
BmEcR homology model using Glide 5.8 docking program. Glide uses a user-defined 
grid to determine the shape and properties of the binding site. The BmEcR grid was 
defined by selecting the center of ponasterone A with otherwise default settings. The 
ligands were first docked and scored according to Glide SP (standard precision) and 
then re-docked with Glide XP (extra-precision) protocol.  Glide Scores (GScores) were 
calculated to estimate the relative binding affinity amongst the ligands for the EcR 
binding site [23]. As part of the default Glide docking procedure, the van der Waals radii 
of non-polar hydrogens were scaled by a factor of 0.8 and all calculations were 
performed with the OPLS-2005 force fields.  
 
  
! 67 
Results 
 As a first step in identifying lead compounds that were capable of inappropriately 
inactivating or inhibiting the BmEcR, an assay based upon transient transfection of 
mammalian cells with the BmEcR, a heterodimeric partner and a secreted Gaussia 
luciferase reporter was developed.  This assay was based upon batch transfection of 
HEK293 cells will three plasmids, followed by culture of the transfected cells in the 
presence of 20HE, a known ligand capable of activating the BmEcR [3].  The mean 
luciferase activity in the media of cells exposed to 20HE ranged from 6.93 to 8.2 fold 
when compared to the media of cells cultured in the absence of 20HE The Z’ value of 
the assay ranged between 6.7- 7.3 (Figure 3.4, Panel A).  These preliminary studies 
demonstrated that the transfected mammalian cell assay has the potential of being used 
to screen for agonists and antagonists of the BmEcR.  However, transient transfection 
of mammalian cells exhibited variation from day to day, and required repeated 
transfections of cells, both of which were impediments to adapting the assay to a high 
throughput format.  To overcome these obstacles, a stable cell line was created that 
incorporated the three cassettes necessary for the assay (the BmEcR LBD, the RXR 
partner and the reporter) into the genome of HEK293 cells. Assays using these cells 
cultured for 24 hours in the presence or absence of 20HE revealed a performance 
comparable or better than that of the assay using the transiently transfected cells, with a 
signal to noise ratio ranged from 4.5 to 5.5 and a Z’ that ranged from 0.78 to 0.88 of the 
assays when conducted on different days (Figure 3.4, Panel B).  
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 The stable cells were used to screen a focused library comprising of 40 
compounds belonging to the diacylhydrazine (DAH), tetrahydroxyquinolone and the 
steroidal ecdysone analog families. These compounds were tested for agonist or 
antagonist activity against BmEcR using the screening strategy mentioned in Materials 
and Methods. The initial screen identified seven compounds as agonists that resulted in 
a significant increase in reporter activity in the stable cells cultured as compared to cells 
cultured in the presence of solvent alone (Figure 3.5, Panel A; p < 0.05, with Bonferroni 
correction for multiple comparisons).  Muristerone and Ponasterone A demonstrated a 
level of agonist activity than the positive control 20HE on the mammalian stable cells. 
Two compounds were identified as antagonists i.e. those that that resulted in a 
significant decrease in reporter activity when added to cells cultured in the presence of 
20HE when compared to cells cultured in the presence of 20HE alone (Figure 3.5, 
Panel B p < 0.05, with Bonferroni correction for multiple comparisons).  
 
 The compounds identified as agonists were then tested at a series of 
concentrations to determine EC50 values for each. EC50 values for the initial hits all were 
low, with some exhibiting values that were in the sub-uM range (Figure 3.6).  The 
agonists were also tested for cytotoxicity as described in Materials and Methods.  None 
of the compounds exhibited cytotoxicity at a concentration of 10 uM.    
 
 A homology model of the BmEcR LBD was then created as described in 
Materials and Methods. The Ramachandaran plots before and after MD simulations 
were created to observe changes in phi-psi distributions. The number of residues within 
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the favored and allowed regions increased from from  89.6%to 98.7% as a result of this 
process (details in supplemental material). Figure 3.7 presents structure of the B. malayi 
EcR LBD homology model with ponasterone A occupying the active site.  
 
 The homology model was used for virtual screening studies of agonists identified 
with the molecular assay above to verify the model performance. The structure with the 
most favorable protein – ligand interaction energy based on the MD simulation 
(according to an RMSD clustering scheme of the final 20 ns) was chosen as the 
representative structure for molecular docking studies. The 3D structures of the ligands 
were docked and scored using both Glide SP (standard precision) and Glide XP (extra 
precision) (Figure 3.8). The predicted lowest energy for each agonist (ligand) is 
described in detail in the supplemental material (see SI). A comparison of computational 
and experimental results is shown in Table 3.1. A Pearson correlation coefficient of 0.78 
was found between experimental log EC50 values and Glide XP docking scores, 
suggesting that the model predictions conformed well with the data collected from the 
mammalian cell assay.  
 
Discussion 
 The experiments described in the first chapter of this thesis have demonstrated 
that 20HE has effects on both embryogenesis and development of B. malayi from the 
infective larvae stage to the adult stage, suggesting that homologues of 20HE may 
represent an important potential chemotherpeutic space for the development of new 
drugs against the human filaria.  Here, we have described the development of  a simple 
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assay with characteristics that make it compatible with a high throughput screening 
format and a homology model for in silico screening that together may be used to 
identify agonists or antagonists targeting the BmEcR.   
 
 As described above, the initial optimization if the assay involved cells transiently 
transfected with three individual plasmids.  While this assay demonstrated a good signal 
to noise ratio and an acceptable Z’ value, this assay required producing transfeced cells 
on a daily basis a peocess that was both cumbersome and subject to day ot day 
variations.  For this reason, we developed a cell line into shich all three of the necessary 
cassettes were inserted into the host cell’s genome.  This assay exhibited performance 
characteristics that equalled or exceeded those of the original assay, but made the 
assay much more amenable to a high throughput format. 
 
 As a first test of the assay, a small library of compuonds that has perviously been 
shown to act as ligands for EcRs of other species, as well as ligands for other members 
of the NHR family were screened for activity aginst the BmEcR.  The results of this 
study suggested that members of the diacylhydrazne family were identifed as ecdysone 
analogs for the Brugia malayi EcR.  This class of compounds has been exploited the 
agricultural industry to develop insecticides targeting insect EcRs that cause precocious 
molting, leading to the death of the the target organism. The DAH bind exclusively to the 
ligand binding domain of the ecdysone receptor. These compounds show high species 
specificity. For example, tebufenozide binds with the lepidopteran ecdysone receptor 
resulting in precocious molting and death of the insect whereas it does no show any 
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activity against the hymenopteran insects ecdysone receptor. There is no evidence of 
detrimental effects of DAH on the vertebrates. The lack of the ecdysone receptor in the 
vertebrates and the species specificity of the DAH make them good chemotherapeutic 
agents for application in the field for treating and preventing lymphatic filariasis. Further 
studies need to be performed to observe the activity of the compounds identified in an 
animal model to guage the performance and efficacy. Other families of compounds like 
tetrahydroquinolones(THQ), butyl-benzamide and acylaminoketone (AAK) have been 
known to be ecdysone agonist. Compounds from these families need to be tested for 
activity against the ecdysone receptor. Focused libraries include compounds showing 
activity against nuclear hormone receptor family, natural extracts from plants and fungii, 
FDA approved drugs and the MMV box could potentially used for screening purposes. 
High throughput screening could also be used to identify novel scaffolds binding the 
receptor. Further, the compounds could be tested individually for activity. Testing of 
these ecdysone analog families and different libraries are essential to identify hits and 
further develop the drug for use.  
 
 To complement the high throughput assay described above, a homology model 
was created for in silico screening of potential ligands against the BmEcR.  When using 
homology models to predict ligand binding, it is important to verify if the resulting models 
are a) likely to be found in nature, b) structurally relatable to other proteins in their family 
(i.e., have the same overall fold), and c) are reproduceable. Thus, with Ramachandaran 
plots and direct comparison to known protein relatives and a model produced by a third 
party, a fairly confident estimate is made that the binding site of the constructed model 
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of the BmEcr LBD likely represents the true binding site. Additionally, the B. malayi 
EcR-LBD’s mechanism is taken into consideration in the model, in that upon binding of 
20-hydroxyecdysone to the EcR LBD, a conformational change allows H12 to interact 
with molting promoter sequence on DNA, which then facilitates DNA transcription of 
molting genes. A protein’s structure and function are intimately related, and thus the fact 
that the procedure was able to capture one of the key functional elements of the EcR 
provides added support for the potential utility of our model in virtual screening studies. 
 
 The B. malayi EcR model was simulated in the NPT ensemble for 65 ns to 
ensure the model was stable and to allow the model to access more relaxed 
conformations. RMSF analysis of all residues illustrated that amino acids within the 
binding site were particularly inflexible with most values < 2Å, which indicates that these 
residues have optimized favorable interactions amongst themselves. Out of the 
converged portions of simulation (i.e., the last 20 ns of simulation) a RMSD clustering 
scheme (as described in the Methods) was employed to find a snapshot that was 
representative of the entire simualtion. This snapshot (less ponasterone A) was used as 
the binding site in virtual screening studies. 
 
 In the analysis of predicted binding poses for each ligand, a pattern was 
observed: orientation of the potential ligands is optimized such that hydrophobic tails 
are buried in a hydrophobic region, while the central gonane structure is surrounded by 
more hydrogen bonding side-chains. The agonists identified in our preliminary screen 
were docked in the EcR LDB, they interacted almost exclusively with the hydrophobic 
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region, which results in very favorable hydrophobic enclosure and lipophilic terms (as 
listed in XP descriptor analyses Table 1).  
 
 The virtual screening results predict that agonist 28 should bind most effectively 
to the B. malayi EcR LBD, however experimental EC50 values indicate that 37 is the 
most efficacious agonist, with 28 following behind in second place. Although the data 
set was small, a relationship was established between calculated Glide Scores and 
experimentally observed EC50.  
 
Conclusions 
In conclusion, the data presented here demonstrates that the high throughput screening 
method could be applicable to screen millions of compounds rapidly with high accuracy 
and reproducibility. The homology model serves as another tool to validate the high 
throughput assay and vice versa. Both, the excellent molecular screening method and 
robust virtual docking study model permit rapid identification and optimization of hits for 
the BmEcR. So far, the DAH family has not been approved for use on a large scale. 
But, the prospects are brighter considering the safety of these drugs [24]. After 
identification of the hits, the compounds could be tested on in-vitro culture of adult 
female worms, L3-stage larvae and microfilariae. The compounds that provide 
substantial effect on the in-vitro culture could be taken to a vertebrate model such as a 
jird. As the jird or gerbils are not natural host, the true efficacy of drugs can be tested in 
a natural host such as a cat or a dog. These robust models of drug discovery could aid 
the drug development filariasis. 
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Tables and Figures 
Table 3.1: XP descriptor analysis given from XP docking of hormones and agonists in B. malayi EcR-LBD binding 
site. 
        XP Descriptors 
Compound EC50 
uM 
Log 
EC50 
GScore EHbond EPhobEn RewLow 
MW 
ELipophilic EElectro EPenalties 
20E 2.34 0.37 -7.253 -1.18 0 -- -5.263 -0.857 0.258 
Muristerone A 0.05 -1.3 -8.285 -2.161 -0.565 -- -4.714 -0.869 0.168 
Ponasterone A 0.04 -1.39 -9.37 -2.547 -0.677 -- -5.427 -0.747 0.233 
Diacylhydrazine # 
28 
0.74 -0.137 -8.613 -0.574 -2 -0.277 -5.001 -0.29 0.184 
Diacylhydrazine # 
37 
0.38 -0.42 -7.497 -0.508 -1.296 -0.278 -5.354 -0.138 0.472 
Diacylhydrazine # 
18 
3.69 0.57 -7.374 -0.545 -0.973 -0.257 -5.3 -0.236 0.238 
Diacylhydrazine # 
38 
0.99 -0.001 -7.269 -0.649 -0.1375 -0.438 -4.869 -0.188 0.473 
Diacylhydrazine # 
36 
2.46 0.397 -6.587 -0.7 -0.869 -0.278 -4.654 -0.111 0.588 
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Figure 3.1: Strategy for production of a stable mammalian cell line for screening 
for agonists and antagonists of the BmEcR.  ‘X” = Gateway recombination cloning. 
Colored circles schematically indicate the specific sequences used in the Gateway 
recombination cloning reactions. 
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Figure 3.2: Strategy for identifying Brugia malayi ecdysone receptor agonists and 
antagonists 
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Figure 3.3: Pipeline used to refine the homology model 
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Figure 3.4: Performance of the mammalian cell assay.  Results of a typical assay 
carried out in a 96 well format are shown.  Columns indicate the mean and error bars 
the standard deviation of six control and six experimental wells.  Assays were 
performed in 96 well plates. Panel A: Assay conducted with the transiently transfected 
cells. Panel B: Assay conducted with the stable cells.   
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Figure 3.5: Agonists and antagonists identified in the screen of compounds 
active against the BmEcR. Horizontal lines indicate the activity expected for 
compounds with no activity as agonists or antagonists.  Panel A:  Compounds with 
agonist activity.  Panel B:  Compounds with antagonist activity.  In each panel, the 
columns labeled “control” represent the light units seen in cells cultured in the absence 
(red columns) or presence (blue columns) of 10uM 20HE.  All columns represent the 
mean and the error bars the standard deviation in triplicate wells.  
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Figure 3.6: EC50 values and structures of agonists identified in the preliminary 
screen of compounds interacting with the BmEcR.  
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Figure 3.7: Cartoon depiction of the B. malayi EcR LBD homology model. The EcR 
is colored by secondary structural element type, with alpha-helices in purple, beta-
sheets in yellow, and flexible loops in white and cyan; alpha-helices are also 
represented as cylinders. Ponasterone A (which was co-crystalized with the template 
structure) occupies the binding site with atoms colored by identity (carbon in gray, 
oxygen in red, hydrogen in white). The figures depict two perspectives of the same 
homology model: a) view with H12, DNA binding element, in the foreground, b) view 
with the beta-sheet and binding pocket in the foreground. 
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Figure 3.8: Predicted structures of agonists docking in the active site of the 
homology model of the BmEcR LBD.  The panels show 20HE, Ponasterone A, 
Musristerone and Diacylhydrazine #28 binding into the active site.  
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CHAPTER FOUR 
 
CONCLUSIONS 
 
 
 The EcR has been highly characterized in insects [1]. It has been used to 
develop compounds that can control the insect population. Targeting of the EcR in 
insects by the agricultural industry has proven fruitful due to the high degree of species 
specificity exhibited by compounds target the EcR, together with an extremely low 
toxicity to vertebrates [2]. Studies show that the nematodes have homolog of both the 
EcR and the heterodimerizing partner RXR [3, 4]. Evidence is presented portraying a 
functional ecdysone-signaling pathway in Brugia malayi [5]. But, the evidence of active 
system in a live parasite is unknown. The data in the first chapter suggested an active 
role played by the BmEcR on embryogenesis. The 20HE treated adult female worms 
aborted high numbers of microfilariae, immature microfilariae and egg/embryos. The 
peak activity was reached within two days under the constant 20HE pressure in culture. 
The data suggests that the 20HE disrupted the reproduction developmental pathway in 
the worms causing precocious and premature expulsion of the life stages by the gravid 
adult females. The expulsion of life stages decreased by day 4 as the pressure of 20HE 
lead to the depletion of uterus. Although, the microfilariae appeared to be normal in the 
culture as compared to the microfilariae given by control untreated females, studies 
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need to be conducted to validate the viability and longevity of the microfilariae born 
under constant 20HE pressure. Further, studies attesting the infectivity of the 
microfilariae also need to be performed The role of the ecdysone receptor on the 
molting on the life stages is yet to be described. To shed a light upon this, an in-vivo 
experiment was conducted with gerbils infected with L3 stage larva under the constant 
pressure of 20HE via a subcutaneous osmotic pump. The data clearly delineates the 
role played by the ecdysone receptor on molting. The parasites implanted in the 
peritoneum of the treated gerbils failed to grow or molt into the next life cycle stage. As 
a result no parasites were recovered from one of the animals. The one female parasite 
recovered from the other treated animal clearly showed signs of growth retardation as 
compared to the parasites recovered from the controls. The thin and short body of the 
parasite suggests that the presence of exogenous ecdysone stimulated precocious molt 
leading to stunted growth of the parasite. This study provided evidence that the 
ecdysone receptor disrupted the normal molting process of the parasite.  
 
 The ecdysone pathway activates expression of a cascade of genes in insects. 
These are the early and late genes controlling the molting, embryogenesis and 
developmental pathways [6-8]. The genes participating in the ecdysone cascade in the 
parasitic nematode Brugia malayi are yet to be identified. The transcriptomic analysis in 
the first study identified the differentially expressed genes on stimulating the ecdysone 
receptor in the adult female worm. Although very few transcripts were identified 
stimulated by the pathway, the robustness of the study was depicted by the high 
correlation of the duplicates samples. Majority of the genes were uncharacterized 
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hypothetical genes. Hence, to assess the functionality of the differentially expressed 
genes apart from the GO annotation, orthologs were identified using the C.elegans 
genome. Orthologs of the genes in C.elegans provide a good comparison of 
functionality over the course of evolution. The RNAi phenotypes of the B. malayi 
orthologs in C.elegans revealed a distinctive pattern that almost all of the genes were 
involved with embryogenesis. These results definitely proved involvement of the 
ecdysone receptor in embryogenesis and developmental pathways of the Brugia malayi.  
 
 More than 390 proteins were found to be more abundant in the treated worms 
when compared with the controls. A total of 11 genes coincided with the transcriptome 
and proteome. The transcriptomic and proteomic studies do not have much correlation, 
which may be attributed to post-transcriptional regulation of protein production, codon 
bias or effects on protein stability [9-14]. Despite this, the proteomic data also identified 
a large proportion of proteins regulating transcription. This supported the overall finding 
of the transcriptome analysis.   
 
 The evidence provided with the first study concluded that the ecdysone receptor 
is functional in the Brugia malayi and regulates embryogenesis and molting. It also 
behaves like a transcriptional factor like other nuclear receptors orchestrating 
expression of genes. The second study focuses on the application of the ecdysone 
receptor as a chemotherapeutic target. The assay based on the mammalian two-hybrid 
system utilized Gaussia princeps luciferase reporter gene along with GAL4BmEcR fuion 
and RXR-VP16 fusion constructs. Mammalian cells transiently transfected with these 
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constructs give a 6-8 fold amplification of signal on addition of 10uM 20HE. The 
drawbacks of this assay were that all the cells do not get transfected with same 
efficiency and the variable transfection efficiency affected the assay performance. 
Although the cells give a higher fold change when transiently transfected, the assay is 
not easily adaptable to a high throughput format. To overcome this obstacle, a stable 
cell line was constructed using the constructs mentioned in chapter two. The 
performance of the assay with the stable cell gave a high Z’ on repeated assays. This 
validated the use of the stable cell line for high throughput format.  
 
 The stable cell line assay was tested for reproducibility before using it to conduct 
the screening of the compounds. After optimization of the assay for a 96 well plate 
format, the assay was ready to use for high throughput screening. Several steroidal and 
non-steroidal ecdysone analogs were tested with the stable cell line assay. Most of the 
compounds belonged to the diacylhydrazine family. This class of compounds has been 
extensively used in agricultural industry as insecticides [15, 16]. A total of seven 
compounds were identified as ecdysone agonists and two as antagonists. The EC50 
values of the compounds were in low molar and sub molar range, suggesting that they 
represent potentially valuable hits for further drug development. Studies need to be 
performed to further refine the hits by performing lead optimization. High throughput 
screening with thousands of synthetic and natural library of compounds could be 
conducted. Further, the assay should be optimized for a 384-well plate. This will 
dramatically increase the number of compounds tested in a high throughput format.  
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 In order to study the ligand-receptor interaction, a homology model of the 
ecdysone receptor was created. Since the crystal structure of the BmEcR was not 
available, the B. tabaci EcR docked with its native substrate ponesterone A was used 
as a template for model development. This hemipteran EcR was found to closely match 
the BmEcR in the initial modeling exercise. The structure of the homology model was 
confirmed using Ramachandran plots and I-Tasser online web server. This study 
successfully developed a homology model for Brugia ecdysone receptor.  
 
 To take the homology model further, a docking study was conducted to validate 
the hits identified on the molecular assay. All the steroidal analogs exhibited the same 
conformation when docked into the active site of the Brugia homology model. They all 
interacted with almost similar residues in the active site. The non-steroidal compounds 
were oriented in a different pattern as of the steroidal compounds. But, they maintained 
the conformation taken by the diacylhydrazine family parent structure. The GlideXP 
scores were calculated of each docked molecule giving an estimation of the binding 
energy. These scores were compared with log EC50 value of each compound. The 
Pearson Correlation coefficient for the docking study and the molecular assay was quite 
high. This study validated the model as an in-silico screening tool to identify new lead 
compounds to bind to the BmEcR.  
 
 The in-silico studies could be utilized to identify novel compounds binding the 
active site of the homology model. Virtual screening could be conducted using ZINC 
compounds database and PDB database to identify hits. Based on the binding scores, 
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the hits could be optimized structurally to bind the active site better. Structure Activity 
Relationship (SAR) studies could help to determine the chemical groups evoking the 
biological activity in the active site of the ecdysone receptor. Further, modifications of 
the compounds can generate novel compounds by means of substitution of a group, 
addition of a group or deletion of a group. Enantiomers of the compounds could also be 
tested virtually for the binding activity. These compounds could be custom synthesized 
in the medicinal chemistry laboratory and tested with the above molecular assay to 
generate EC50 and cytotoxic profile. Other libraries like focused NHR libraries, fungal 
extracts, ecdysone analogs library could be tested. The hits identified and optimized 
would to be tested in in-vitro and in-vivo model to observe performance and any side 
effects. The in-vitro models include soaking the compounds with adult female worms 
culture, L-3 stage larva culture and microfilarial culture. The drugs that pass the in-vitro 
testing could be taken to the animal model. The most widely used animal for the study is 
a gerbil. But, the gerbils are not a natural host for the B. malayi. The compounds can be 
tested for pilot in-vivo assays in gerbils. But, in order to gauge the true efficacy and 
performance of the drugs, a natural host such as a cat or a ferret would serve as a 
better model. The D. immitis dog model of the worm could also be used towards B. 
malayi as dogs can harbor natural infection. A robust pharmacological profile of the 
compound could be retrieved using a natural host.  
 
 The scope of this project was to develop an idea that could be aid the drug 
development against filariasis. Using the EcR is a rational choice as its natural absence 
in the vertebrates can minimize any pleotropic effects. The study validated that the 
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BmEcR is playing an important role on embryogenesis and molting in the filarial worm. 
These are important targets for the drug development arena to combat filariasis. 
Additionally, drugs identified against the Brugia ecdysone receptor are likely to work on 
other filarial worms like Onchocerca volvulus without giving severe adverse reactions. 
With the development of an assay and homology model further aided the drug discovery 
process and high throughput format could screen thousands of compounds in a short 
span of time.  
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APPENDICES 
 
 
Appendix for Chapter One 
 
Table S1: Primers and probes used for the real time PCR 
 
Amplicon 
Size (bp) Gene  Primer 
104 Bm58 Forward 5' ACGAGCAACAGGACTTGT 3' 
    Reverse 5' AACGACCACCTTCAGGT 3' 
    Probe 
5' FAM-
TCACTTGTACATCGCTATTTAACTGGTGCT -
BHQ1 3' 
83 Bm12555 Forward 5' CTTTCGTAGAACGGTTCGTG 3' 
    Reverse 5' CGTTACGACCAGCTTTATCAA 3' 
    Probe 5' FAM-ACGTGTGTCGTTATGAGCAGAAGTGT-BHQ1 3' 
103 Bm11454 Forward 5' GTGGAGGATACGGTTATGGTAAA 3' 
    Reverse 5' CTGATAGCAATATCATACCCTCTATAT 3' 
    Probe 5' FAM-AAATTGCCGAGATGGGTGCCTACG-BHQ1 3' 
123 Bm7925 Forward 5' GAACCAGAAACGCTGAAAGTG 3'  
    Reverse 5' CCGATATGATGGTCGTCGATT 3' 
    Probe 5' FAM-AATCAGTGACGATGAGGCACGA-BHQ1 3' 
105 Bm2121 Forward 5' GCTTATAAAGCTGGATTTATTGGC 3' 
  (NADH) Reverse 5' TGTTTCTTCACCACATATATAGGC 3' 
    Probe 5' HEX-ACGTATTCGTTCATCGAGGTGCTGG-BHQ1 3' 
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Appendix for Chapter Two 
 
 Homology model construction and validation 
In order to validate the EcR homology model, PROCHECK was used to compile a 
Ramachandran plot, or plotted distribution of the backbone (ϕ,ψ) dihedrals[1]. 
PROCHECK validates that our homology model has backbone dihedral distribution very 
similar to that of “natural” protein structures with 89.6 % of (ϕ,ψ)  pairs present in the 
most favored regions.  To verify the reproducibility of our homology model, we used the 
online homology modeling web-server I-TASSER [2], to create a second homology 
model using third party procedures for comparison purposes. The Figure SI-1 
summarizes the pipeline used to create the homology model.  Our homology model 
retained the same secondary and tertiary structures in comparison with the top ranked I-
TASSER homology model.  The Figure SI-2 shows the superposition of Prime 
homology model over I-Tasser homology model.   
  
  A Ramachandaran plot was compiled to compare the distribution of backbone 
dihedrals (phi-psi) of our EcR homology model to the known distributions of these 
dihedrals amongst all crystallized proteins in the Protein Data Bank. 89.6% of all amino 
acids in our homology model had phi-psi dihedral pairs plotted within “favored” regions 
of backbone conformations, i.e.,  regions that are highly populated by amino-acids in 
“nature-made” polypeptides. This result supports that our constructed homology model 
is very similar to most described proteins with regards to backbone orientation which 
relates to minimization of backbone strain. 
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 Ecdysone receptors from Bemisa tabaci and Heliothis vericens insect species 
have been crystalized and described. As proteins with the same functions as, and 
closely related to the B. malayi EcR, these structures will serve as guides to scrutinizing 
the predicted teriary elements of our B. malayi EcR homology model. Our model 
exhibits 10 of the 11 expected α-helices and the one expected β-sheet comprised of 
three strands, when compared to B. tabaci and H. vericens EcR crystal structures. The 
model also exhibits the same general fold common to the EcR family: 11 to 12 alpha 
helices arranged antiparallel with respect to their neighbors and stacked in three 
“layers” with one beta-sheet encompassing one side of the binding pocket. Additionally, 
our homology modeling protocol was able to predict the placement of α-helix-12 (H12), 
a secondary structural element that is crucial to the function of the EcR.  
  
 The online wed-server, I-TASSER, which constructs homology models from 
submitted sequences, was used to construct a second homology model of the BmEcR-
LBD to compare to our model constructed with Schrodinger’s Prime module. As is 
shown in Figure SI-3, our model and the I-TASSER generated model agree on 
placement of secondary structural elements and the overall EcR fold is present in both. 
Furthermore, the two structures agree on placement of residues within the binding site.  
 
 Homology model refinement 
 To refine the homology model further, by allowing it to access more relaxed 
conformations, and to ensure the model was stable, it was simulated with molecular 
dynamics (MD) simulations in CHARMM (Chemistry at HARvard Molecular Modeling) 
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the biomolecular simulation program[3], CHARMMing [4] and pdbtools 
(https://github.com/JoaoRodrigues/pdb-tools) were used to convert the homology model 
to a CHARMM compatible version and to generate necessary topology and coordinate 
files. The protein was treated with CHARMM (C36) force-fields and parameters for 
substrate ponesterone A were generated using the CHARMM generalized force-field 
(CGenFF) via the Paramchem Web-interface [5]. A total of 76,128 TIP3 water 
molecules were added to solvate the homology model, and waters that overlapped with 
protein atoms were deleted. The resulting system was a cubic box of 80 x 80 x 80 Å 
with the EcR model at the center. Next, the system was neutralized by adding sodium 
and chlorine ions sequentially, replacing random water molecules, until the total salt 
concentration was 0.15 M NaCl. This neutralization step was followed by short (10 
steps) of steepest descent (SD) minimization and then 25 steps of Adopted Basis 
Newton-Raphson (ABNR) minimization to alleviate steric clashes that may have arisen 
during the ion placement. Slowly the system was heated from 100 K to 300 K for 100 ps 
and after heating the system was equilibrated and simulated for a period of 65 ns under 
isobaric-isothermal conditions (NPT ensemble).  A 2 fs integration time step was used, 
and snapshots were saved for every 1000 steps (2 ps). The SHAKE algorithm 
constrained covalent bonds to hydrogen atoms. Particle mesh Ewald (PME) was used 
for evaluating long-range electrostatics and a 12Å cut-off was used to calculate LJ-
nonbonded terms. To improve computational speed, the 65ns simulation was conducted 
with GPU accelerate code and the CHARMM/OpenMM interface[6]. To monitor the 
structural stability and convergence of the homology model across the trajectory, 
structural properties like radius of gyration (Rg), root mean square deviation (RMSD), 
! 98 
root mean square fluctuation (RMSF) and total energy of the system were reported. 
These time correlated properties are shown in Figure 4 a,b,c. Additionally, root mean 
square fluctuation (RMSF) was calculated for each residue (using the complete 65ns 
trajectory) to estimate which regions of the EcR model are most or least flexible. RMSD 
and Rg plots support that the model was equilibrated within the first 20 ns of simulation.  
Total energy also remains stable, fluctuating steadily around ~ -140500 kcal/mol; with 
no large total energy drifting indicated in Figure SI-4c, it is apparent that the simulation 
is converged. RMSFs are given in Figure SI-4d and Table SI-1 for those residues within 
3Å of the hormone binding site. As most residues presented in Table SI-1 below exhibit 
RMSFs of < 2Å, binding site residues are relatively inflexible during MD simulations.  
 
 Virtual Screening Studies: 
In order to obtain a single snapshot that represented the equilibrated portion of 
the 65 ns trajectory, all frames from the last 20 ns were clustered according to an 
RMSD cut-off in CHARMM’s CORREL module, this resulted in 10 unique clusters. 
Then, the interaction energy between ponasterone A and the protein system was 
calculated for each frame in the highest populated cluster.  The frame with the lowest 
(most favorable) interaction energy was chosen as the representative structure of B. 
malayi’s EcR, and this structure was used as the binding site during docking studies.  
The lowest energy pose (as predicted by Glide Score) of 20-hydroxyecdysone bound 
in B. malayi EcR predicts the hormone’s hydrophobic tail to be supported via van der 
Waals interactions to several residues including Leu44, Ile120, Phe119, Tyr41, Ile222, 
and Ile220. However, the central gonane structure of 20-hydroxecdysone, is surrounded 
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by residues in the binding pocket of similar character to itself including Thr89, Thr48, 
Tyr116 as well as some hydrophobic residues, Leu47, Leu85, and Val100. GlideXP 
docking also predicts on the other side of the binding pocket, Arg88’s NH2 will donate a 
hydrogen bond to C3-OH of 20-hydroxecdysone. Ecdysone is also predicted to bind in 
the EcR LBD binding pocket such that the hydrophobic tail can interact with a collection 
of mostly hydrophobic residues -- including Ile120, Tyr116, Tyr41, and Leu85 -- while 
C25-OH of the tail accepts a hydrogen bond within this hydrophobic pocket from Tyr41-
OH. Additionally, as also seen with 20-hydroxyecdysone, ecdysone’s C3-OH accepts a 
hydrogen bond from Arg88-NH2. Muristerone A is oriented similarly to 20-
hydroxyecdysone and ecdysone in the EcR LBD binding pocket with the hydrophobic 
tail interacting heavily via van der Waal and hydrophobic contacts to Ile120, Phe119, 
Tyr41, and Leu44. Muristerone A’s C3-OH also participates in hydrogen bonding, this 
time donating a hydrogen bond to Thr22-OH. Ponasterone A is also oriented in the 
binding site with the hydrophobic tail interacting with the grouped hydrophobic residues 
on one side, and the more polar end of the molecule interacting via hydrogen bonding. 
Leu85, Leu120, Phe128, and Met127 interact via van der Waals contacts with the tail 
and similar to 20-hydroxyecdysone and ecdysone, Arg88-NH2 donates a hydrogen bond 
to C3-OH of ponasterone A. 
 
 Out of all agonists, compound 28 has the lowest Glide Score. Compound “28” 
is predicted to bind in the hydrophobic region of the binding pocket; out of the 17 
residues within 5Å of compound 28, 16 are hydrophobic (within 3Å of 28: Ile120, 
Met127, Thr48, Leu85, Leu44, Val100, and Tyr116, within 5Å of 28: Leu47, Phe128, 
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Leu123, Ile222, Tyr41, Phe119, Val86, Ile215, Ile220, Ala131, Leu102). GlideXP 
predicts compound 28, with two aromatic rings, participates in aromatic interactions to 
Tyr41 and Tyr116, both of parallel displaced style aromatic interaction. Additionally, 
much of the binding energy should be attributed to van der Waals interactions between 
alkyl substituents on the ligand and hydrophobic residues in the binding site including 
Val100, Met 127, Leu85, and Leu44. The Glide docking score Table 3.1 predicts 
compound 28 binds most favorably out of six agonists with GScore of -8.613, and this is 
largely due to the highly favorable hydrophobic enclosure term of -2.000 and the 
lipophilic term of -5.001.  
 
 Like 28, Compound “34”, is too predicted to bind in the hydrophobic pocket and 
interact mostly via van der Waals terms to Ile120, Met127, and Tyr116. However, 
binding of 34 is unique as it exhibits electrostatic interactions between charged Arg88 
side chain and the three fluorines of compound 34. Additionally, 34 donates a hydrogen 
bond to Thr89OH. Compound 34 has a GScore of -8.132, which is composed most 
notably of the hydrophobic enclosure term (-1.575), the Hbond term (-0.700), the 
lipophilic term (-5.289), and the electrostatic term (-0.400). This electrostatic contribution 
is the most favorable electrostatic contribution seen amongst all six agonists, and is 
likely a result of the interaction between Arg88 and fluorine atoms. 
 
 Compound “37” binds in the hydrophobic binding pocket and is supported by 
van der Waals interactions to Ile120, Phe128, Ala124, Tyr116, and Leu85. Compound 
37 also donates a weak (as the angle is not optimal) hydrogen bond to Thr89-OH. The 
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calculated GScore for 37 is -7.497, with largest contributing terms again being the 
hydrophobic enclosure (-1.296) and the lipophilic term (-5.354). 
 
 Compound “18” is predicted to also bind in the hydrophobic pocket and interact 
mostly via van der Waals terms to Ile120, Leu102, Leu44, Ile222, and Ile215. 
Compound 18 is also predicted, like 28, to form parallel-displaced aromatic interactions 
to Tyr116 and to Phe128. The calculated GScore is -7.374 for 18, with the highest 
contributions again from the hydrophobic enclosure term (-0.973) and the lipophilic term 
(-5.3).  
 
 Compound “38” binds in the hydrophobic pocket and interacts via van der 
Waals terms to Tyr116, Ile120, Ile120, Leu44, Phe128, and Leu47. Additionally, Tyr116 
forms a parallel-displaced aromatic interaction to compound 38’s aromatic ring and 
Thr48 accepts a hydrogen bond from compound 38’s-NH. Compound 38 has a GScore 
of -7.269, and again with the most prominent terms being the hydrophobic enclosure 
term (-0.649) and the lipophilic term (-4.869). 
 
 Finally Compound “36” binds in the hydrophobic binding pocket, and similarly 
interacts with Leu102, Val100, Phe128, Leu85, Ile120, and Ala124 via van der Waals 
contacts. GlideXP also predicts compound 36 will donate a hydrogen bond, from a 
nitrogen hydrogen, to Thr89-OH. Compound 36 has a GScore of -6.587 with the 
hydrophobic enclosure term contributing -0.700 and the lipophilic term contributing -
4.654.  
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 Tables and Figures 
Table SI-1: Summary of RMSFs calculated from the MD simulation of for all 
residues within 3 Å of the 20-hydroxyecdysone binding site. Residue name is given 
on the left of each column and the RMSF is given to on the right, residues are ordered 
by their residue number. Polar residues are highlighted in blue, hydrophobic residues 
are listed in black and those residues constituting the “hydrophobic pocket” are 
underlined. 
Residue RMSF(Å)  Residue RMSF(Å)  Residue RMSF(Å)  Residue RMSF(Å) 
Thr25 4.0197  Leu54 1.0319  Gly103 1.0891  Ala124 1.5249 
Tyr41 1.4307  Leu85 1.0164  Leu102 1.2015  Met127 1.8614 
Leu44 1.4337  Arg88 1.0116  Tyr116 1.5545  Phe128 1.6413 
Leu47 0.9546  Thr89 0.8653  Phe119 2.1285  Ile220 2.2800 
Thr48 0.8501  Cys92 1.2423  Ile120 1.8953  Ile222 2.7519 
Ser51 0.6974  Val100 1.1788  Ile123 2.4866    
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Table SI-2: Summary of the phi-psi distribution for amino acids in the EcR-LBD 
homology model. The sum of the first two percentages indicates the number of 
residues in more favored regions (98.7%).  
Number of residues in favored regions 90.5% 
Number of residues in allowed regions 8.2% 
Number of residues in outlier region 1.3% 
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Figure SI- 1: Pipeline to create homology model 
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Figure SI-2: Superposition of Prime homology model(yellow) over I-Tasser 
homology model (blue). 
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Figure SI-3: Ramachandaran plot compiled of the phi-psi backbone dihedrals 
from the model after molecular dynamics simulations.  The legend illustrates the 
color designations of certain regions in the plot. 
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Figure SI-4: MD simulation results: a) RMSD plotted over the course of 65 ns 
simulation, b) radius of gyration plotted over the course of 65 ns simulation, c) total 
energy of the homology model and ponasterone A complex monitored over the course 
of 65 ns simulation, and d) RMSF analysis for each residue in the EcR LBD homology 
model.  
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